{
  "meta": {
    "title": "00387_Late_Night_Pyq_Pyt_Medicine-2_1",
    "url": "https://brainandscalpel.vercel.app/00387-late-night-pyq-pyt-medicine-2-1-9f0ad7f9.html",
    "scrapedAt": "2025-11-29T17:29:36.035Z"
  },
  "questions": [
    {
      "id": 46462,
      "choices": [
        {
          "id": 185467,
          "text": "<p><span style=\"font-size:12.0pt;\">In severe aortic regurgitation, the murmur has a lower pitch&nbsp;</span></p>"
        },
        {
          "id": 185468,
          "text": "<p><span style=\"font-size:12.0pt;\">In severe aortic regurgitation, the murmur is of the crescendo type&nbsp;</span></p>"
        },
        {
          "id": 185469,
          "text": "<p><span style=\"font-size:12.0pt;\">In severe aortic regurgitation, the murmur has a softer intensity&nbsp;</span></p>"
        },
        {
          "id": 185470,
          "text": "<p><span style=\"font-size:12.0pt;\">In severe aortic regurgitation, the murmur has a briefer duration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How does the murmur of severe aortic regurgitation differ from that of mild aortic regurgitation?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">( NEET PG 2015 )</span></p>",
      "unique_key": "Q7623476",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365510,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) In severe aortic regurgitation, the murmur has a briefer duration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The murmur associated with severe aortic regurgitation is significantly shorter in duration compared to the murmur of mild aortic regurgitation. In mild cases, the regurgitant murmur is longer because the pressure gradient between the aorta and left ventricle takes more time to equalize. However, as the severity of the regurgitation increases, this pressure equalization occurs more rapidly, resulting in a markedly shortened murmur duration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While the intensity of the murmur may increase slightly with severe regurgitation, the most notable difference lies in the considerably reduced duration of the murmur. Regardless of severity, the typical aortic regurgitation murmur is a high-pitched, early diastolic, decrescendo murmur best heard at Erb's point (the third intercostal space on the left) with the patient sitting up, leaning forward, and at end-expiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>A.</strong> The pitch of the aortic regurgitation murmur remains high regardless of severity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>B</strong>. Aortic regurgitation murmurs are decrescendo (diminishing) in character, not crescendo (increasing).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>C.</strong> The intensity of the murmur may actually increase slightly with severe regurgitation, not become softer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe aortic regurgitation is characterized by a significantly shorter murmur duration compared to mild aortic regurgitation due to the rapid equalization of pressure between the aorta and left ventricle.</span></p>",
      "correct_choice_id": 185470,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50954,
      "choices": [
        {
          "id": 203357,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest wall neuromuscular disease&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203358,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203359,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic pulmonary fibrosis&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203360,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows a normal graph on the left and the patient&#39;s graph on the right. Which of the following diagnoses can be inferred from the graph? (</span></span></span></span>INICET Nov 2023)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-112354.png\" style=\"height:188px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q8251401",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365457,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The spirometry graph compares a normal patient&#39;s lung function with that of the patient. The normal graph shows an FEV1/FVC ratio (Forced Expiratory Volume in 1 second / Forced Vital Capacity) of more than 70%, which is typical in healthy individuals. In contrast, the patient&#39;s graph shows a significantly reduced FEV1/FVC ratio of approximately 50-55%, indicating an obstructive lung disease. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive lung diseases are characterized by reduced airflow due to airway narrowing or obstruction, leading to a lower FEV1/FVC ratio. The common obstructive lung diseases include asthma, emphysema, chronic bronchitis, COPD, bronchiectasis, and cystic fibrosis. Among the given options, bronchiectasis is the only obstructive lung disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chest wall neuromuscular disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This typically causes restrictive lung disease, not obstructive, and would present with a normal or high FEV1/FVC ratio but reduced lung volumes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sarcoidosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is an interstitial lung disease, which is restrictive. It would show a normal or elevated FEV1/FVC ratio with reduced lung volumes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Idiopathic pulmonary fibrosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Another interstitial lung disease leading to restrictive patterns on spirometry, characterized by a normal or high FEV1/FVC ratio with reduced total lung capacity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A reduced FEV1/FVC ratio (&lt;70%) is indicative of obstructive lung disease. Among the given options, bronchiectasis is the obstructive lung disease associated with this spirometry pattern.</span></span></p>",
      "correct_choice_id": 203360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50952,
      "choices": [
        {
          "id": 203349,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203350,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ursodeoxycholic acid and lifestyle modification&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203351,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modifications and vitamin E&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203352,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone and lifestyle modifications&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with a history of consumption of 2-3 drinks per week comes with complaints of right upper quadrant discomfort. He has grade 2 steatosis. His BMI was 29 kg/m&sup2; and AST and ALT levels were slightly elevated. What would you advise him?&nbsp;</span></span>(INICET Nov 2023)</p>",
      "unique_key": "Q5694344",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365462,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is likely suffering from non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH), given his history of minimal alcohol consumption, grade 2 steatosis, elevated BMI, and mildly elevated liver enzymes (AST and ALT). The cornerstone of treatment for NASH is lifestyle modification and weight loss. These interventions help reduce liver fat, inflammation, and fibrosis. No FDA-approved medications currently exist for the treatment of NASH; thus, lifestyle changes are the primary recommended approach.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ursodeoxycholic acid and lifestyle modification:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ursodeoxycholic acid is used for primary biliary cholangitis, not NASH, and thus is not appropriate here.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lifestyle modifications and vitamin E:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin E can be used off-label in non-diabetic patients with NASH but is not FDA-approved or considered first-line treatment. It can be considered but is secondary to lifestyle changes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pioglitazone and lifestyle modifications:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone, along with other medications like metformin and GLP-1 receptor agonists, is sometimes used off-label for diabetic patients with NASH. However, it is not FDA-approved for NASH and should not be the first-line recommendation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss are the primary and most effective treatments for non-alcoholic steatohepatitis (NASH), as no FDA-approved medications are currently available for this condition.</span></span></span></span></p>",
      "correct_choice_id": 203349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11308,
      "choices": [
        {
          "id": 45198,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add long-acting nitrate</span></span></p>"
        },
        {
          "id": 45199,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase metoprolol dose to 100mg BID</span></span></p>"
        },
        {
          "id": 45200,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add clopidogrel 75mg OD</span></span></p>"
        },
        {
          "id": 45201,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start enoxaparin 1mg/kg s.c BD</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 53-year-old gentleman presents with chest pain which is happening at rest. Pain is persistent for 3-5 minutes and he is having recurrent pain over the last 48 hours and he used 3 puffs of GTN to relieve his pain. His current medications include GTN PRN, Atorvastatin 20mg HS, Metoprolol 50mg BID, and Aspirin 75mg OD. His troponin was negative and ECG showed LVH with flattening of the ST segment. What is the most appropriate next step in management?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q6273281",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365474,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Start enoxaparin 1mg/kg s.c BD</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is presenting with symptoms suggestive of unstable angina, given the recurrent chest pain at rest and ECG changes (left ventricular hypertrophy with ST segment flattening). Despite the negative troponin, which rules out myocardial infarction, the clinical scenario points to a high risk of acute coronary syndrome (ACS).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For high-risk ACS, especially in a patient already on medications for coronary artery disease (CAD) like aspirin, atorvastatin, and metoprolol, initiating anticoagulation therapy is crucial to prevent thrombus formation and progression to myocardial infarction. <strong>Enoxaparin</strong>, a low molecular weight heparin, is recommended at a therapeutic dose of 1 mg/kg subcutaneously twice a day to achieve effective anticoagulation in this setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Add long-acting nitrate:</span></strong><span style=\"font-size:12.0pt\"> While long-acting nitrates can help with angina symptoms, they are not the primary treatment for acute management in this scenario. The priority is to stabilize the patient and prevent further thrombotic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increase metoprolol dose to 100mg BID:</span></strong><span style=\"font-size:12.0pt\"> Increasing the dose of metoprolol may help with angina control, but it does not address the underlying risk of thrombus formation and is not the immediate next step in managing high-risk unstable angina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Add clopidogrel 75mg OD:</span></strong><span style=\"font-size:12.0pt\"> Clopidogrel is an antiplatelet agent that is beneficial in ACS, but in this acute setting, starting anticoagulation with enoxaparin takes precedence to prevent thrombus formation. Clopidogrel can be added as part of dual antiplatelet therapy later on.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with high-risk unstable angina, especially those with recurrent chest pain at rest and ECG changes, initiating therapeutic anticoagulation with enoxaparin is a critical step in the acute management to prevent thrombus formation and progression to myocardial infarction.</span></span></p>",
      "correct_choice_id": 45201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45087,
      "choices": [
        {
          "id": 179995,
          "text": "<p><span style=\"font-size:12.0pt;\">Must be distinguished from Pulsus Alternans</span></p>"
        },
        {
          "id": 179996,
          "text": "<p><span style=\"font-size:16px;\">Is a sign of digitalis toxicity</span></p>"
        },
        {
          "id": 179997,
          "text": "<p><span style=\"font-size:16px;\">Compensatory pause is absent</span></p>"
        },
        {
          "id": 179998,
          "text": "<p><span style=\"font-size:16px;\">Rhythm is irregular</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">All of the following statements about Pulsus Bigeminus are true, except?<strong>&nbsp;</strong>(NEET PG 2017)</span></p>",
      "unique_key": "Q8423175",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365467,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: C. Compensatory pause is absent</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Pulsus bigeminus is characterized by a normal beat followed by a premature ventricular contraction (PVC), creating a pattern where every other beat appears weaker. This creates an alternating strong-weak pulse pattern. Importantly, PVCs typically have a compensatory pause following them, as the ventricle is refractory to the next normal sinus impulse.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Must be distinguished from Pulsus Alternans:</strong>&nbsp; Pulsus bigeminus must be distinguished from pulsus alternans as they present differently. Pulsus alternans is associated with severe left ventricular dysfunction, while pulsus bigeminus is due to premature beats.</p><p>&nbsp;</p><p><strong>Option B. Is a sign of digitalis toxicity</strong>: Digitalis toxicity can produce various dysrhythmias including premature ventricular contractions in a bigeminal pattern. It's a classic manifestation of digoxin toxicity.</p><p>&nbsp;</p><p><strong>Option D. Rhythm is irregular:&nbsp;</strong>Pulsus bigeminus demonstrates an irregular rhythm with normal sinus beats interrupted by premature ventricular contractions.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Pulsus bigeminus is an irregular cardiac rhythm characterized by normal beats alternating with premature ventricular contractions, which are typically followed by compensatory pauses as the ventricle is refractory to the next sinus impulse.</p>",
      "correct_choice_id": 179997,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11506,
      "choices": [
        {
          "id": 45990,
          "text": "<p><span style=\"font-size:12.0pt;\">Retrolentiform</span></p>"
        },
        {
          "id": 45991,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior limb</span></p>"
        },
        {
          "id": 45992,
          "text": "<p><span style=\"font-size:12.0pt;\">Sublentiform</span></p>"
        },
        {
          "id": 45993,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior limb</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which part of the internal capsule is affected in hemiplegia due to ischemic stroke? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q9207152",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;Posterior Limb</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The posterior limb of the internal capsule is the most commonly affected area in cases of hemiplegia due to ischemic stroke. This area carries the corticospinal tract, which is essential for motor control. When the posterior limb is compromised, it disrupts the corticospinal pathway, leading to muscle weakness or paralysis on the opposite side of the body from the lesion.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture36.jpg\" alt=\"\" width=\"500\" height=\"425\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture37.jpg\" alt=\"\" width=\"1000\" height=\"723\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Retrolentiform:&nbsp;</strong>Primarily involved in visual processing. Damage here would likely lead to visual field defects rather than motor dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anterior limb:&nbsp;</strong>Primarily associated with cognitive and emotional functions due to its connectivity between the thalamus and the frontal lobe. Lesions here generally do not cause hemiplegia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sublentiform:&nbsp;</strong>Involved in auditory and gustatory pathways, thus unrelated to motor control functions affected in hemiplegia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of ischemic stroke, damage to the posterior limb of the internal capsule results in hemiplegia because of the disruption of corticospinal tracts. This knowledge aids in accurate stroke localization and informs rehabilitation strategies to help regain motor functions.</span></p>",
      "correct_choice_id": 45993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54262,
      "choices": [
        {
          "id": 216517,
          "text": "<p><span style=\"font-size:12.0pt;\">Evolocumab</span></p>"
        },
        {
          "id": 216518,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 216519,
          "text": "<p><span style=\"font-size:12.0pt;\">Evinacumab</span></p>"
        },
        {
          "id": 216520,
          "text": "<p><span style=\"font-size:12.0pt;\">Everolimus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a PCSK-9 inhibitor?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2206072",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365503,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Evolocumab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCSK-9 inhibitors are a class of drugs that significantly lower LDL cholesterol levels by inhibiting the protein PCSK-9, which in turn increases the number of LDL receptors available to clear LDL cholesterol from the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">There are only 2 PCSK-9 inhibitors: Evolocumab and alirocumab. Among the options provided:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a well-known PCSK-9 inhibitor used in modern clinical practice to manage hyperlipidemia, particularly in patients with familial hypercholesterolemia or those who are at high risk of cardiovascular events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Ezetimibe</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Ezetimibe is an NPC1L1 transport inhibitor, also known as an intestinal cholesterol absorption inhibitor. It reduces blood cholesterol by decreasing the absorption of cholesterol in the small intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Evinacumab</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Evinacumab is a newer drug that acts as an ANGPTL3 inhibitor. It is specifically approved for use in patients with familial homozygous type 2 hyperlipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Everolimus</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Everolimus is an mTOR inhibitor and an immunosuppressive drug used primarily in organ transplantation and certain types of cancer. It is not related to the treatment of dyslipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a PCSK-9 inhibitor used to significantly lower LDL cholesterol levels, particularly in high-risk patients.</span></p>",
      "correct_choice_id": 216517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46458,
      "choices": [
        {
          "id": 185451,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 185452,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        },
        {
          "id": 185453,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 185454,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was admitted to the casualty with hysteria and anxiety. Estimation of arterial plasma showed pH of 7.53; HCO₃ of 18 meq and Pco₂ of 27 mm Hg. Which of the following is the patient’s primary disorder?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2014)</span></p>",
      "unique_key": "Q4014150",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365461,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Respiratory alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arterial blood gas (ABG) analysis suggests that the primary acid-base disorder is respiratory alkalosis. Here’s a step-by-step approach to determine the disorder:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Assess the pH:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Normal pH: 7.35 – 7.45</span></li><li><span style=\"font-size:12.0pt;\">Patient’s pH: 7.53 (indicates alkalosis)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Determine the primary disturbance:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">pCO₂ (Respiratory Component):</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Normal range: 35 – 45 mm Hg</span></li><li><span style=\"font-size:12.0pt;\">Patient’s pCO₂: 27 mm Hg (decreased, indicates alkalosis)</span></li><li><span style=\"font-size:12.0pt;\">Since the pCO₂ is decreased and corresponds with the alkaline pH, the primary disorder is respiratory.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">HCO₃ (Metabolic Component):</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Normal range: 22 – 28 meq/L</span></li><li><span style=\"font-size:12.0pt;\">Patient’s HCO₃: 18 meq/L (decreased, indicates acidosis)</span></li><li><span style=\"font-size:12.0pt;\">The decreased HCO₃ does not align with the alkaline pH, indicating it is a compensatory response.</span></li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\">Conclude the diagnosis:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Primary disorder: Respiratory alkalosis (due to decreased pCO₂)</span></li><li><span style=\"font-size:12.0pt;\">Compensatory mechanism: Metabolic acidosis (decreased HCO₃)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Therefore, the primary disorder is respiratory alkalosis with a compensatory metabolic acidosis.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metabolic acidosis</strong>: This would present with a low pH (&lt; 7.35) and decreased HCO₃.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metabolic alkalosis</strong>: This would present with an increased pH (&gt; 7.45) and increased HCO₃.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory acidosis</strong>: This would present with a low pH (&lt; 7.35) and increased pCO₂.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary disorder is determined by the component (pCO₂ or HCO₃) that aligns with the pH. In this case, respiratory alkalosis is indicated by decreased pCO₂ and an increased pH.</span></p>",
      "correct_choice_id": 185454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11809,
      "choices": [
        {
          "id": 47202,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, and 5</span></p>"
        },
        {
          "id": 47203,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 5 only</span></p>"
        },
        {
          "id": 47204,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4, 5 only</span></p>"
        },
        {
          "id": 47205,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4, and 5 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient came to the outpatient department with complaints of neck swelling. She gives a history of weight loss and palpitations. On examination, she has exophthalmos and a diffusely enlarged thyroid gland. What are the essential investigations that should be done for the patient? (INICET NOV 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Thyroid scan</span></li><li><span style=\"font-size:12.0pt;\">Fine needle aspiration cytology (FNAC)</span></li><li><span style=\"font-size:12.0pt;\">Thyroid function tests</span></li><li><span style=\"font-size:12.0pt;\">Ultrasound of neck</span></li><li><span style=\"font-size:12.0pt;\">Anti-thyroid antibody</span></li></ol>",
      "unique_key": "Q5537454",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365469,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 3, 4, and 5 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of neck swelling, weight loss, palpitations, exophthalmos, and a diffusely enlarged thyroid gland suggests hyperthyroidism, likely Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FNAC is not recommended in this case because it does not provide additional diagnostic yield for Graves' disease, does not alter the treatment plan, and carries a risk of complications due to the gland's increased vascularity in Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The following investigations are essential:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1<strong>. Thyroid scan</strong>: A radioactive iodine uptake scan helps differentiate between diffuse uptake (indicative of Graves' disease) and nodular uptake (indicative of toxic multinodular goiter or Plummer's disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3.<strong> Thyroid function tests</strong>: These are crucial as they provide information on the levels of thyroid hormones (T3, T4) and thyroid-stimulating hormone (TSH), helping confirm the diagnosis of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4<strong>. Ultrasound of neck</strong>: This imaging modality helps assess the thyroid gland's structure and can reveal increased vascularity, which is characteristic of Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">5. <strong>Anti-thyroid antibody</strong>: Testing for antibodies, such as TSH receptor antibodies (TRAbs) or thyroid-stimulating immunoglobulins (TSI), is important for diagnosing autoimmune thyroid diseases like Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient with clinical signs of hyperthyroidism and a diffusely enlarged thyroid gland, essential investigations include a thyroid scan, thyroid function tests, ultrasound of the neck, and anti-thyroid antibody tests. Fine needle aspiration cytology (FNAC) is not typically required in these cases.</span></p>",
      "correct_choice_id": 47205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66053,
      "choices": [
        {
          "id": 263361,
          "text": "<p><span style=\"font-size:12.0pt;\">High TSH levels</span></p>"
        },
        {
          "id": 263362,
          "text": "<p><span style=\"font-size:12.0pt;\">High free T4 levels</span></p>"
        },
        {
          "id": 263363,
          "text": "<p><span style=\"font-size:12.0pt;\">High serum T3 levels</span></p>"
        },
        {
          "id": 263364,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive iodine uptake (RAIU) at 24 hours above normal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A middle-aged woman who presented with fatigue, dry skin, weight gain, and menstrual irregularities is diagnosed with Hashimoto's thyroiditis. Which of the following statements would be correct with respect to her thyroid function test? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q1520726",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ana. A) High TSH levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hashimoto’s thyroiditis</strong> is an autoimmune condition resulting in hypothyroidism due to destruction of thyroid tissue. Key thyroid function test findings include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>High TSH levels:</strong> As thyroid hormone (T3, T4) levels decline, the pituitary gland increases TSH secretion to stimulate the thyroid.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low free T4 and T3 levels:</strong> Reflecting decreased thyroid hormone production.</span></li><li><span style=\"font-size:12.0pt;\"><strong>RAIU at 24 hours below normal:</strong> Thyroid destruction leads to reduced iodine uptake.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. High free T4 levels:</strong> Incorrect because free T4 is typically low in hypothyroidism due to reduced thyroid hormone production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. High serum T3 levels:</strong> Incorrect because T3 levels are also reduced in hypothyroidism, though they may decline later than T4.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. RAIU at 24 hours above normal:</strong> Incorrect because iodine uptake is reduced in Hashimoto's thyroiditis due to thyroid destruction, unlike hyperthyroid states like Graves' disease where uptake is increased.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In Hashimoto’s thyroiditis, high TSH levels reflect the pituitary’s attempt to compensate for decreased thyroid hormone levels, a hallmark of hypothyroidism. RAIU is typically reduced due to thyroid destruction. Early detection and appropriate thyroid hormone replacement can prevent complications.</span></p>",
      "correct_choice_id": 263361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45178,
      "choices": [
        {
          "id": 180359,
          "text": "<p><span style=\"font-size:16px;\">TYPE 1</span></p>"
        },
        {
          "id": 180360,
          "text": "<p><span style=\"font-size:16px;\">TYPE 2</span></p>"
        },
        {
          "id": 180361,
          "text": "<p><span style=\"font-size:16px;\">TYPE 3</span></p>"
        },
        {
          "id": 180362,
          "text": "<p><span style=\"font-size:16px;\">TYPE 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What subtype of Bartter’s syndrome is linked to barttin mutations? NEET 2016:</span></p>",
      "unique_key": "Q6171873",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365507,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Type 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Type 4 Bartter’s syndrome is specifically associated with mutations in the barttin protein. This type of the syndrome is characterized by the presence of sensorineural deafness alongside the typical symptoms of Bartter’s syndrome such as salt-wasting and hypokalemic metabolic alkalosis. Barttin is an essential subunit that supports the function of chloride channels, crucial for ion transport processes in the kidney. Mutations here disrupt these processes significantly, mimicking the effects of loop diuretics and leading to the severe manifestation of symptoms seen in this subtype.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-181452.png\" alt=\"\" width=\"1000\" height=\"536\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Type 1:</strong> Incorrect because it involves mutations in the Na-K-2Cl pump, not barttin.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Type 2:</strong> Incorrect as it involves mutations in the ROMK potassium channel, unrelated to barttin.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Type 3:</strong> Incorrect since it is associated with mutations in the chloride channel ClC-Kb, distinct from barttin mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Type 4 Bartter’s syndrome is the subtype associated with mutations in barttin and is accompanied by sensorineural deafness.</span></p>",
      "correct_choice_id": 180362,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11972,
      "choices": [
        {
          "id": 47853,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 47854,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 47855,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 47856,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following types of headaches requires further evaluation? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Headache for &gt; 4 hours</span></li><li><span style=\"font-size:12.0pt;\">Worst headache of life</span></li><li><span style=\"font-size:12.0pt;\">New-onset progressive headache</span></li><li><span style=\"font-size:12.0pt;\">Headache with blurring of vision</span></li></ol>",
      "unique_key": "Q6718845",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365487,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;C) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Certain types of headaches can be indicative of serious underlying conditions and thus require further evaluation to rule out life-threatening or severe pathologies:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Worst headache of life:</strong> This is a classic description of a subarachnoid hemorrhage, which is a medical emergency. Patients experiencing this type of headache require immediate medical attention and thorough investigation, typically involving neuroimaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. New-onset progressive headache:</strong> Progressive headaches, especially those that are new in onset and occur in adults, raise concern for potential serious conditions such as brain tumors or other intracranial pathologies. These headaches warrant detailed medical evaluation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Headache with blurring of vision:</strong> This symptom combination suggests possible increased intracranial pressure, which can be associated with conditions like papilledema or optic neuritis. Such cases need prompt assessment to determine the cause and appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Headache for &gt; 4 hours:</strong> While a headache lasting more than four hours can be distressing, it is not necessarily indicative of a severe underlying condition. Such headaches could be primary headaches like tension-type headaches or migraines, which often do not require immediate further evaluation unless they have other alarming features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Headaches described as the \"worst headache of life,\" new-onset progressive headaches, and headaches accompanied by blurring of vision require further medical evaluation to rule out serious conditions.</span></p>",
      "correct_choice_id": 47855,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11354,
      "choices": [
        {
          "id": 45382,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sarcoidosis</span></span></span></p>"
        },
        {
          "id": 45383,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
        },
        {
          "id": 45384,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphoma</span></span></span></p>"
        },
        {
          "id": 45385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypersensitive pneumonitis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents to you with fever, night sweats, ptosis, and bilateral facial nerve palsy. Investigations showed leukocytosis and bilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q4214208",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365495,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Sarcoidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with fever, night sweats, ptosis, and bilateral facial nerve palsy. The investigations show leukocytosis and bilateral hilar lymphadenopathy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hilar lymphadenopathy can be seen in many conditions like Sarcoidosis, Pneumoconiosis, TB, etc</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">But the other clinical features point towards sarcoidosis, a systemic inflammatory disease characterized by non-caseating granulomas. Sarcoidosis can affect multiple organs, but it commonly involves the lungs and lymph nodes. Bilateral hilar lymphadenopathy is a hallmark finding in sarcoidosis and is often the first clue in diagnosis. Additionally, sarcoidosis can present with systemic symptoms like fever and night sweats.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of bilateral facial nerve palsy is another significant clue. While Guillain-Barre syndrome, Lyme disease, and sarcoidosis can cause bilateral lower motor neuron (LMN) type facial palsy, the combination of other symptoms and bilateral hilar lymphadenopathy strongly favors sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Tuberculosis: </span></strong><span style=\"font-size:12.0pt\">Tuberculosis (TB) can present with fever, night sweats, and lymphadenopathy, including hilar lymphadenopathy. However, TB typically causes caseating granulomas and does not commonly present with bilateral facial nerve palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Lymphoma</strong>: Lymphoma can also present with fever, night sweats, and lymphadenopathy. However, it typically involves systemic B symptoms and other lymph node groups. Bilateral facial nerve palsy is not a common presentation of lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Hypersensitive pneumonitis</span></strong><span style=\"font-size:12.0pt\">: Hypersensitive pneumonitis can present with respiratory symptoms and lymphadenopathy, but it is usually associated with exposure to inhaled organic antigens. It does not typically cause systemic symptoms like fever, night sweats, and bilateral facial nerve palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral hilar lymphadenopathy with systemic symptoms like fever and night sweats and the presence of bilateral facial nerve palsy is highly suggestive of sarcoidosis. Always consider sarcoidosis first in such clinical scenarios.</span></span></p>",
      "correct_choice_id": 45382,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45577,
      "choices": [
        {
          "id": 181947,
          "text": "<p><span style=\"font-size:16px;\">Subthalamus</span></p>"
        },
        {
          "id": 181948,
          "text": "<p><span style=\"font-size:16px;\">Globus pallidus</span></p>"
        },
        {
          "id": 181949,
          "text": "<p><span style=\"font-size:16px;\">Substantia nigra</span></p>"
        },
        {
          "id": 181950,
          "text": "<p><span style=\"font-size:16px;\">Striatum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What part of the brain is primarily damaged in cases of chorea? (NEET PG 2016)</span></p>",
      "unique_key": "Q7550284",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365456,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D. Striatum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Chorea is characterized by rapid, involuntary, and random movements that primarily result from damage to the striatum, a key component of the basal ganglia. The striatum, which includes the caudate nucleus and putamen, plays a critical role in the modulation of movement. Damage or dysfunction in this area disrupts the normal inhibitory and excitatory signals necessary for smooth and controlled motion. This disruption often leads to the characteristic jerky movements associated with chorea. Conditions such as Huntington’s disease, which involve significant degeneration of neuronal cells in the striatum, are classic causes of chorea.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Subthalamus:</strong> Incorrect as lesions here typically result in hemiballismus, not chorea.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Globus pallidus:</strong> Incorrect because although it's part of the basal ganglia, damage here is more typically associated with dystonia and athetosis rather than chorea.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Substantia nigra:</strong> Incorrect, as damage to this area is primarily associated with Parkinson’s disease, leading to symptoms like bradykinesia and tremor, not chorea.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Chorea is predominantly due to damage in the striatum, part of the basal ganglia, which leads to uncontrollable, quick movements due to the disruption of motor control</span></p>",
      "correct_choice_id": 181950,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54263,
      "choices": [
        {
          "id": 216521,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        },
        {
          "id": 216522,
          "text": "<p><span style=\"font-size:12.0pt;\">Lepirudin</span></p>"
        },
        {
          "id": 216523,
          "text": "<p><span style=\"font-size:12.0pt;\">Fondaparinux</span></p>"
        },
        {
          "id": 216524,
          "text": "<p><span style=\"font-size:12.0pt;\">Dabigatran</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anticoagulants requires coagulation profile monitoring?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3370230",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365504,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Lepirudin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lepirudin is a parenteral direct thrombin inhibitor, which requires routine coagulation profile monitoring. The standard test used for monitoring Lepirudin is the activated partial thromboplastin time (aPTT). In cath labs, when administering in high doses need to be monitor with ACT (Activated Clotting Time) rather than aPTT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is necessary to ensure the correct therapeutic range is maintained and to avoid complications such as bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - There are four parenteral direct thrombin inhibitors: lepirudin, hirudin, bivalirudin, and argatroban.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Enoxaparin</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Enoxaparin is a low molecular weight heparin (LMWH). It has a predictable anticoagulant effect, and routine coagulation monitoring is generally not required under standard clinical circumstances. In special situations, monitoring can be done using anti-factor Xa levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Fondaparinux</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Fondaparinux, like Enoxaparin, does not typically require routine coagulation monitoring due to its predictable pharmacokinetics and pharmacodynamics. In specific clinical scenarios, anti-factor Xa levels may be measured.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Dabigatran</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Dabigatran is an oral direct thrombin inhibitor and is classified under direct oral anticoagulants (DOACs). Routine coagulation monitoring is not required due to its reliable and predictable effects. However, if monitoring is needed, aPTT can be used, though more specific tests like the dilute thrombin time (dTT) or the ecarin clotting time (ECT) are preferred for accurate measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note </strong>- There are four DOACs (Direct Oral Anticoagulants): Dabigatran (direct thrombin inhibitor), Apixaban, Rivaroxaban and Edoxaban (all 3 are factor Xa inhibitor)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lepirudin, a parenteral direct thrombin inhibitor, requires routine coagulation profile monitoring using aPTT to ensure therapeutic efficacy and safety.</span></p>",
      "correct_choice_id": 216522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20264,
      "choices": [
        {
          "id": 81017,
          "text": "<p><span style=\"font-size:12.0pt;\">Flunarizine</span></p>"
        },
        {
          "id": 81018,
          "text": "<p><span style=\"font-size:12.0pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 81019,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 81020,
          "text": "<p><span style=\"font-size:12.0pt;\">Topiramate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management? (NEET PG 2023)</span></p>",
      "unique_key": "Q4176157",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365472,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Sumatriptan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms are characteristic of a migraine, which is often associated with unilateral headache, nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sumatriptan:</strong> This medication is a serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. It works by stimulating serotonin (5-HT) receptors in the brain, leading to vasoconstriction of dilated blood vessels and relief from migraine symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best drug for acute management of a migraine attack in this scenario is Sumatriptan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Flunarizine:</strong> This is a calcium channel blocker used for the prophylactic treatment of migraine, not for acute management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Propranolol:</strong> This beta-blocker is also used for migraine prophylaxis, not for acute attacks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Topiramate:</strong> Used for preventing migraine, not for treating an acute attack.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educaitonal Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sumatriptan is the best medication for the acute management of migraine, characterized by unilateral headache, nausea, photophobia, and phonophobia.</span></p>",
      "correct_choice_id": 81018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11246,
      "choices": [
        {
          "id": 44950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV immunoglobulins</span></span></span></span></p>"
        },
        {
          "id": 44951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids</span></span></span></span></p>"
        },
        {
          "id": 44952,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy</span></span></p>"
        },
        {
          "id": 44953,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood transfusion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the best treatment for idiopathic thrombocytic purpura? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q7790833",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365499,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Splenectomy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy is considered the best long-term treatment option for patients with chronic ITP who do not respond to medical therapies such as steroids or immunoglobulins. The procedure involves removing the spleen, which is a site of platelet destruction in ITP. Removing the spleen often results in a permanent increase in platelet count, though it is typically reserved for patients who are refractory to first-line treatments.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Approach to ITP:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If severe ITP @ presentation: <strong>Transfusion+ steroids</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intracranial/GI Bleed</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PC &lt; 5k</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large oral bleed/Retinal bleed</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low dose steroids recommended in all cases of ITP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If steroid unresponsive, decision depends on duration:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent (3-12 months):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rituximab vs TPO-RA (Romiplostim (S. C.), Eltrombopag (Oral) </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>(&gt;12 months):</strong> Rituximab vs Splenectomy vs TPO-RA</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If still persistent/refractory, possible options are:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fostamatinib:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SyK (Tyrosine kinase inhibitor)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMF/Cyclophosphamide/Azathioprine</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autologous stem cell transplant<strong><u> </u></strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IV immunoglobulins:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used as a first-line treatment, especially for acute cases of ITP or in severe cases to quickly raise the platelet count, but not as a long-term solution.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Steroids:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common first-line treatment for ITP that can effectively increase platelet count in many patients, though many eventually relapse upon discontinuation or become steroid-dependent.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Blood transfusion:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Generally not a primary treatment for ITP since the issue is not the quantity of produced platelets but their premature destruction; transfusions might be used in acute, severe bleeding scenarios but do not address the underlying autoimmune process.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy is often considered the best treatment option for chronic or refractory idiopathic thrombocytopenic purpura, particularly when other treatments such as steroids and IV immunoglobulins fail to maintain a safe platelet count or cause side effects that are difficult to manage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: ASH 2021 summary</span></span></strong></p>",
      "correct_choice_id": 44952,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11245,
      "choices": [
        {
          "id": 44946,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory condition</span></span></p>"
        },
        {
          "id": 44947,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Descending paralysis is seen</span></span></p>"
        },
        {
          "id": 44948,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmapheresis is a treatment method</span></span></p>"
        },
        {
          "id": 44949,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Demyelinating disorder</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about Typical Guillain-Barre syndrome except: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q8290426",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365497,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Descending paralysis is seen</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guillain-Barre Syndrome (GBS) is typically characterized by ascending paralysis, starting from the lower extremities and moving upward, not descending paralysis. This pattern begins with weakness in the legs that spreads to the upper limbs and the face, associated with the demyelination of peripheral nerves. The condition is indeed inflammatory and primarily affects the peripheral nervous system, leading to demyelination and sometimes axonal damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inflammatory condition:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS is an acute inflammatory demyelinating polyneuropathy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plasmapheresis is a treatment method:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, plasmapheresis is used to remove antibodies from the blood that are thought to be involved in the immune attack on the peripheral nerves.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Demyelinating disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS involves the demyelination of peripheral nerves, leading to muscle weakness and paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GBS produces neuro-radiculopathy due to demyelination causing ascending paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes of Descending paralysis (<strong>Mnemonic: Bipolar disorder [BPD]</strong>):</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B: B</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">otulism</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P: P</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">orphyria, Polio</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D: D</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">iphtheria</span></span></span></span></p>",
      "correct_choice_id": 44947,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11355,
      "choices": [
        {
          "id": 45386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Consolidation</span></span></span></p>"
        },
        {
          "id": 45387,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mass</span></span></span></p>"
        },
        {
          "id": 45388,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pleural effusion</span></span></span></p>"
        },
        {
          "id": 45389,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diaphragmatic hernia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old female patient presents to you with fever, breathlessness, and cough with expectoration. A CT scan was done which is shown below. What is the most likely diagnosis? (Neet pg 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191655.jpg\" style=\"height:253px; width:400px\" /></p>",
      "unique_key": "Q7104903",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365496,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Consolidation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s symptoms of fever, breathlessness, and cough with expectoration suggest an infectious process in the lungs. The CT scan provided shows a large area of increased density (whitish patch) in the right lung, particularly in the lower lobe. This area is accompanied by air bronchograms, which are dark branching structures representing air-filled bronchi within the consolidated lung tissue. The presence of air bronchograms is a classic sign of consolidation, which indicates that the alveoli are filled with inflammatory exudates, cells, or other materials, typically due to pneumonia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Mass:</strong> A mass would appear as a localized, well-defined lesion in the lung tissue without the characteristic air bronchograms seen in consolidation. It would not typically present with diffuse symptoms like those described (fever, breathlessness, and productive cough).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Pleural Effusion:</span></strong><span style=\"font-size:12.0pt\"> Pleural effusion involves the accumulation of fluid in the pleural space surrounding the lungs. On imaging, it appears as a homogenous opacity at the lung base with a meniscus sign. It does not show air bronchograms and typically does not present with the same radiographic features as consolidation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Diaphragmatic Hernia:</span></strong><span style=\"font-size:12.0pt\"> A diaphragmatic hernia involves the protrusion of abdominal contents into the thoracic cavity through a defect in the diaphragm. This condition would appear on imaging as abdominal organs (e.g., intestines) within the chest cavity, not as a consolidation pattern with air bronchograms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consolidation in the lung, often due to pneumonia, is characterized by a homogenous area of increased density with air bronchograms on imaging, and presents with symptoms such as fever, breathlessness, and productive cough.</span></span></p>",
      "correct_choice_id": 45386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11540,
      "choices": [
        {
          "id": 46126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium oxalate</span></span></span></p>"
        },
        {
          "id": 46127,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium phosphate</span></span></span></p>"
        },
        {
          "id": 46128,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uric acid</span></span></span></p>"
        },
        {
          "id": 46129,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystine</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the urinary crystal shown below? (INICET MAY 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-155713.png\" style=\"height:245px; width:300px\" /></span></span></p>",
      "unique_key": "Q3213675",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365464,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A) Calcium oxalate</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium oxalate crystals are typically bipyramidal or envelope-shaped. These crystals are common in various conditions, including hyperoxaluria and ethylene glycol poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B. Calcium phosphate: </strong>&nbsp;crystals form asymmetric rosettes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Uric acid: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;crystals are rhomboid forming rosettes, </span><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">polychromatophilic in Polarized Microscope.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cystine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;crystals are hexagonal, and </span><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">one of the hardest crystals. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - Monohydrate crystal &ndash; dumbbell shaped</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium oxalate crystals are bipyramidal or envelope-shaped.</span></span></span></p>",
      "correct_choice_id": 46126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11400,
      "choices": [
        {
          "id": 45566,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Aminoglycoside and colistin</span></p>"
        },
        {
          "id": 45567,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cotrimoxazole with 3rd generation cephalosporin</span></p>"
        },
        {
          "id": 45568,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Carbapenems and 3rd generation cephalosporin</span></p>"
        },
        {
          "id": 45569,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cefepime and tigecycline</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 43-year-old patient presented with spikes of fever and difficulty in breathing. Transesophageal echo revealed vegetations in the heart. The culture was positive for Burkholderia cepacia. Which of the following is the first line of management? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q6175202",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365463,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cotrimoxazole with 3rd generation cephalosporins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is B, Cotrimoxazole with 3rd generation cephalosporins. This combination is effective against Burkholderia cepacia, a pathogen known for its resistance to many standard antibiotics. The standard regimen includes Cotrimoxazole (trimethoprim-sulfamethoxazole), which has broad-spectrum bacterial coverage, combined with a 3rd generation cephalosporin such as ceftazidime or cefoperazone-sulbactam to cover for the pathogen's unique resistance profiles and aggressive infection nature, especially in immunocompromised patients or those with existing cardiac issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aminoglycoside and colistin:</strong> This option is incorrect due to the intrinsic resistance of Burkholderia cepacia to aminoglycosides. While colistin could still be effective, the resistance to aminoglycosides limits this combination's usefulness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbapenems and 3rd generation cephalosporin:</strong> Incorrect because the combination of carbapenems with cephalosporins is generally not recommended. They both share a similar mechanism of action, inhibiting bacterial cell wall synthesis, and could potentially compete for the same binding sites, thus reducing their effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cefepime and tigecycline:</strong> Incorrect because tigecycline is not particularly effective against Burkholderia cepacia. Cefepime alone would not sufficiently manage the infection due to the bacteria's robust resistance profile.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The standard regimen for Burkholderia cepacia is cotrimoxazole with ceftazidime /cefoperazone-sulbactam.</span></p>",
      "correct_choice_id": 45567,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11208,
      "choices": [
        {
          "id": 44798,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ANCA</span></span></p>"
        },
        {
          "id": 44799,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RA factor</span></span></span></span></p>"
        },
        {
          "id": 44800,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbsAg</span></span></p>"
        },
        {
          "id": 44801,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DIF </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A elderly patient presents with cutaneous vasculitis, glomerulonephritis, and peripheral neuropathy. Which investigation should be performed next to help you diagnose the condition? (NEET PG 2018)</span></span></p>",
      "unique_key": "Q3391099",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365490,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. ANCA</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical features of cutaneous vasculitis, glomerulonephritis, and peripheral neuropathy are suggestive of a systemic vasculitis affecting small vessels. Anti-neutrophil cytoplasmic antibodies (ANCA) are associated with certain types of small vessel vasculitis, making ANCA testing the next appropriate step in the diagnostic process. The presence of ANCA, depending on its pattern&mdash;c-ANCA typically associated with granulomatosis with polyangiitis (formerly Wegener&rsquo;s granulomatosis) and p-ANCA with microscopic polyangiitis and Churg-Strauss syndrome&mdash;helps in confirming the diagnosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. RA factor:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although rheumatoid factor (RA factor) can be elevated in conditions like mixed cryoglobulinemia, which might present similarly, it is less specific for diagnosing small vessel vasculitis compared to ANCA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. HbsAg:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatitis B surface antigen (HbsAg) could be relevant if considering hepatitis B associated vasculitis, but given the clinical presentation, it is less likely the cause of these symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. DIF (Direct Immunofluorescence):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While useful in diagnosing immune complex deposition diseases such as immune-complex mediated vasculitis, it is not as directly diagnostic of ANCA-associated vasculitis as ANCA testing itself.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Features are suggestive of small vessel vasculitis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163807.jpg\" style=\"height:437px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Vasculitis syndrome/Chap 363</span></span></strong></span></span></p>",
      "correct_choice_id": 44798,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66050,
      "choices": [
        {
          "id": 263349,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium bicarbonate</span></p>"
        },
        {
          "id": 263350,
          "text": "<p><span style=\"font-size:12.0pt;\">N-acetylcysteine</span></p>"
        },
        {
          "id": 263351,
          "text": "<p><span style=\"font-size:12.0pt;\">Ursodeoxycholic acid</span></p>"
        },
        {
          "id": 263352,
          "text": "<p><span style=\"font-size:12.0pt;\">Dopamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents to the emergency department after ingesting an unknown quantity of amitriptyline tablets. He develops confusion, seizures, and wide QRS complexes on ECG. Which of the following can be used in the management of this condition? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q3986514",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365451,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Sodium bicarbonate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation suggests <strong>amitriptyline toxicity</strong>, a tricyclic antidepressant overdose. Amitriptyline overdose is known to cause:</span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Confusion and seizures:</strong> Due to central nervous system toxicity.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Wide QRS complexes on ECG:</strong> A hallmark of sodium channel blockade, which can lead to life-threatening arrhythmias.</span></li></ul><p><span style=\"font-size:12.0pt;\"><strong>Sodium bicarbonate</strong> is the treatment of choice for tricyclic antidepressant overdose with wide QRS complexes. It works by:</span></p><ol><li><span style=\"font-size:12.0pt;\"><strong>Alkalinizing the blood:</strong> Reduces binding of the drug to sodium channels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increasing extracellular sodium:</strong> Helps overcome the sodium channel blockade, stabilizing cardiac membranes.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. N-acetylcysteine:</strong> Incorrect because it is the antidote for paracetamol toxicity, not for tricyclic antidepressant overdose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ursodeoxycholic acid:</strong> Incorrect because it is used in cholestatic liver diseases and has no role in managing tricyclic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dopamine:</strong> Incorrect because it is used to improve renal perfusion in shock and does not address sodium channel blockade or arrhythmias caused by amitriptyline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Sodium bicarbonate is the first-line treatment for tricyclic antidepressant overdose with cardiotoxicity, such as wide QRS complexes. Early recognition and treatment are essential to prevent life-threatening arrhythmias and seizures.</span></p>",
      "correct_choice_id": 263349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66056,
      "choices": [
        {
          "id": 263373,
          "text": "<p><span style=\"font-size:12.0pt;\">Lead pipe appearance</span></p>"
        },
        {
          "id": 263374,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous involvement</span></p>"
        },
        {
          "id": 263375,
          "text": "<p><span style=\"font-size:12.0pt;\">Transmural involvement</span></p>"
        },
        {
          "id": 263376,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectal involvement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are features of ulcerative colitis except: <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q9710669",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365455,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Transmural involvement</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Incorrect because transmural inflammation is a hallmark of Crohn's disease, not UC.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Ulcerative colitis (UC)</strong> is a chronic inflammatory bowel disease characterized by the following:</span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lead pipe appearance:</strong> A classic radiological feature due to loss of haustral folds, typically seen in chronic UC.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Continuous involvement:</strong> Inflammation in UC is continuous, starting from the rectum and extending proximally in a uniform pattern, unlike the skip lesions of Crohn's disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Rectal involvement:</strong> The rectum is almost always involved in UC.</span></li></ul><p><span style=\"font-size:12.0pt;\">UC is <strong>limited to the mucosa and submucosa</strong>, and it does not involve the entire thickness (transmural involvement) of the bowel wall, unlike Crohn's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lead pipe appearance:</strong> Correct for UC, reflecting chronic inflammation and fibrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Continuous involvement:</strong> Correct because UC has a uniform pattern of inflammation without skip lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rectal involvement:</strong> Correct because UC typically involves the rectum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Ulcerative colitis is characterized by continuous inflammation limited to the mucosa and submucosa, often with rectal involvement and a \"lead pipe appearance\" on imaging. Transmural involvement is a distinguishing feature of Crohn's disease</span></p>",
      "correct_choice_id": 263375,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55351,
      "choices": [
        {
          "id": 220865,
          "text": "<p><span style=\"font-size:12pt;\">Increased afterload</span></p>"
        },
        {
          "id": 220866,
          "text": "<p><span style=\"font-size:12pt;\">Decreased preload</span></p>"
        },
        {
          "id": 220867,
          "text": "<p><span style=\"font-size:12pt;\">High systemic vascular resistance</span></p>"
        },
        {
          "id": 220868,
          "text": "<p><span style=\"font-size:12pt;\">Decreased contractility</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient after RTA (Road Traffic Accident) presented with hypovolemic shock. What is the reason for decreased cardiac output in this patient? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q9289820",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365482,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Decreased preload</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hypovolemic shock, often caused by significant blood loss as in the case of a road traffic accident (RTA), leads to a decrease in the volume of blood returning to the heart (preload). Preload is the initial stretching of the cardiac myocytes prior to contraction, which is directly related to the volume of blood filling the heart. When there is a significant loss of blood volume, the preload decreases, leading to a reduced stroke volume and, consequently, decreased cardiac output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increased afterload:</strong> This refers to the resistance the heart must overcome to eject blood. Increased afterload is not a primary issue in hypovolemic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. High systemic vascular resistance:</strong> This would be more characteristic of distributive shock, such as septic shock, rather than hypovolemic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Decreased contractility:</strong> While decreased contractility can reduce cardiac output, in hypovolemic shock, the primary problem is the loss of blood volume leading to decreased preload, not a primary issue with the heart muscle's ability to contract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In hypovolemic shock, the primary cause of decreased cardiac output is decreased preload due to significant loss of blood volume.</span></p>",
      "correct_choice_id": 220866,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11504,
      "choices": [
        {
          "id": 45982,
          "text": "<p><span style=\"font-size:12.0pt;\">Seizures</span></p>"
        },
        {
          "id": 45983,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 45984,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral neuropathy</span></p>"
        },
        {
          "id": 45985,
          "text": "<p><span style=\"font-size:12.0pt;\">Uremic pericarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Dialysis will prevent all except? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q6646423",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365500,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Peripheral Neuropathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dialysis is effective in removing many waste products and toxins from the blood, which can alleviate a range of symptoms associated with uremia. However, it is less effective in preventing or reversing complications that arise from the accumulation of middle molecular weight substances, such as those implicated in peripheral neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture35.jpg\" alt=\"\" width=\"1000\" height=\"314\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peripheral neuropathy in dialysis patients is largely attributed to the build-up of middle molecular weight molecules like beta 2 microglobulin, which are not efficiently removed by standard dialysis membranes. Native kidneys or high-flux dialyzers are more effective at removing these molecules, but even these can have limited efficacy. Peripheral neuropathy is thus a complication less responsive to conventional dialysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Seizures:&nbsp;</strong>These are often caused by severe uremia or electrolyte imbalances, both of which can be effectively managed through dialysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metabolic acidosis:&nbsp;</strong>Dialysis helps correct metabolic acidosis by removing excess acids from the blood and restoring bicarbonate levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Uremic pericarditis:&nbsp;</strong>Uremic toxins that contribute to inflammatory conditions such as pericarditis are effectively removed through dialysis, thereby preventing this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While dialysis effectively manages many complications of renal failure such as seizures, metabolic acidosis, and uremic pericarditis, it is less effective for peripheral neuropathy due to its limited ability to remove middle molecular weight toxins that contribute to nerve damage. Ongoing management and treatment strategies need to consider these limitations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Nephrology, Dialysis</strong></span></p>",
      "correct_choice_id": 45984,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11640,
      "choices": [
        {
          "id": 46526,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 46527,
          "text": "<p><span style=\"font-size:12.0pt;\">4.5</span></p>"
        },
        {
          "id": 46528,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 46529,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25yr old woman came to OPD one year after the birth of her last child. She had been treated for iron deficiency anemia while pregnant. On examination, she is pale, and investigations show a HB of 5mg/dl and a reticulocyte count of 9%. What is her corrected reticulocyte count ? (take normal Hb as 15mg/dl) (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q8710483",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365488,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corrected reticulocyte count (CRC)= reticulocyte % X (actual Hb/normal Hb)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC= 9 X 5/15 = 3%</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC can also be calculated using hematocrit</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC= Reticulocyte % X (Actual PCV/ normal PCV )</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corrected reticulocyte count (CRC) adjusts the observed reticulocyte percentage to reflect the degree of anemia by using the patient's actual hemoglobin compared to a normal hemoglobin level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corrected reticulocyte count is crucial for assessing bone marrow response in anemic patients, providing insight into whether the bone marrow is responding appropriately to the anemia. This is particularly important in managing patients with iron deficiency anemia to monitor recovery or response to therapy.</span></p>",
      "correct_choice_id": 46528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11593,
      "choices": [
        {
          "id": 46338,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood glucose &lt;40 mg/dL</span></span></span></p>"
        },
        {
          "id": 46339,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arterial pH &gt;7.2</span></span></span></p>"
        },
        {
          "id": 46340,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum creatinine - 5.2</span></span></span></p>"
        },
        {
          "id": 46341,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Unarousable coma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old man presents with 15 days of fever and altered sensorium for 1 day. A rapid diagnostic test was done, and Plasmodium falciparum was diagnosed. Which of the following is not a complication?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q5491345",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365491,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Arterial pH &gt;7.2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An <strong>arterial pH &gt;7.2</strong>, however, is not considered a complication of severe malaria. In fact, severe acidosis is defined by an arterial pH of less than 7.25, and it is a sign of severe malaria. Therefore, an arterial pH &gt;7.2 does not indicate severe malaria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Plasmodium falciparum malaria is a severe form of malaria that can lead to numerous complications. The World Health Organization (WHO) defines several criteria for severe malaria, many of which are seen in complicated cases of Plasmodium falciparum infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Blood glucose &lt;40 mg/dL</span></strong><span style=\"font-size:12.0pt\">: Severe hypoglycemia is a known complication of severe malaria, particularly in patients treated with quinine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum creatinine - 5.2</span></strong><span style=\"font-size:12.0pt\">: This indicates severe renal impairment. Serum creatinine levels above 3 mg/dL or reduced urine output despite rehydration are markers of severe malaria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Unarousable coma</span></strong><span style=\"font-size:12.0pt\">: Cerebral malaria, which includes unarousable coma or seizures, is one of the most severe complications of Plasmodium falciparum infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diagnostic criteria for identifying complicated falciparum malaria, based on clinical and laboratory findings:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Arterial pH</span></strong><span style=\"font-size:12.0pt\">: An arterial pH of less than 7.25 is indicative of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bicarbonate Levels</span></strong><span style=\"font-size:12.0pt\">: A bicarbonate level of less than 15 is also a sign of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Base Deficit</span></strong><span style=\"font-size:12.0pt\">: A base deficit of more than 8 is another indicator of severe disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hemoglobin</span></strong><span style=\"font-size:12.0pt\">: A hemoglobin level of less than 5, or the presence of hemoglobinuria, are significant markers of severity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Venous Lactate</span></strong><span style=\"font-size:12.0pt\">: A venous lactate level of more than 5 further confirms the complexity and severity of the malaria infection.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Blood Glucose</span></strong><span style=\"font-size:12.0pt\">: A blood glucose level less than 40 mg/dL is a critical indicator of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Creatinine Levels</span></strong><span style=\"font-size:12.0pt\">: A creatinine level exceeding 3 mg/dL points to significant renal impairment associated with severe malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Urine Output</span></strong><span style=\"font-size:12.0pt\">: A urine output of less than 400 mL per day, despite adequate rehydration with IV fluids, also signifies complicated falciparum malaria.</span></span></span></li>\r\n</ol>",
      "correct_choice_id": 46339,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11799,
      "choices": [
        {
          "id": 47162,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral sumatriptan</span></span></p>"
        },
        {
          "id": 47163,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subcutaneous sumatriptan</span></span></p>"
        },
        {
          "id": 47164,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 6 L/minute</span></span></p>"
        },
        {
          "id": 47165,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 8 L/minute</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment of choice for an acute attack of cluster headache is: (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q3285611",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365465,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subcutaneous sumatriptan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Subcutaneous sumatriptan is shown to be effective in treating acute attacks of cluster headaches. The reference indicates that oral sumatriptan is not effective, whereas subcutaneous sumatriptan has been proven beneficial. I</span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">ntranasal&nbsp;sumatriptan and intranasal zolmitriptan also are shown to be effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, 100% oxygen therapy at a rate of at least 12 liters per minute is effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral sumatriptan:</span></strong><span style=\"font-size:12.0pt\"> Oral sumatriptan has not been shown to be effective in treating acute cluster headache attacks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 100% oxygen at 6 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Although 100% oxygen is a treatment option, the effective rate is at least 12 liters per minute, making 6 L/minute inadequate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 100% oxygen at 8 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Similar to the previous option, 8 L/minute is below the effective rate of 12 liters per minute required for treating acute cluster headaches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of choice for an acute attack of cluster headache is subcutaneous sumatriptan, and 100% oxygen therapy should be administered at a rate of at least 12 liters per minute for effectiveness.</span></span></span></p>",
      "correct_choice_id": 47163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11309,
      "choices": [
        {
          "id": 45202,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CXR PA view</span></span></p>"
        },
        {
          "id": 45203,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trans-esophageal echocardiography</span></span></p>"
        },
        {
          "id": 45204,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI</span></span></p>"
        },
        {
          "id": 45205,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Troponin assay</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male presented with substernal chest discomfort. On examination, he was hypotensive, drowsy, and had unequal pulses. Which of the following investigations would be the best in this situation to ascertain the diagnosis?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>",
      "unique_key": "Q5528001",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365475,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Trans-esophageal echocardiography</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presentation of acute chest pain, hypotension, drowsiness, and unequal pulses strongly suggests aortic dissection. <strong>Aortic dissection</strong> is a life-threatening condition that requires immediate diagnosis and management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trans-esophageal echocardiography (TEE) is highly sensitive and specific for diagnosing aortic dissection. It can be performed at the bedside, making it ideal for unstable patients. TEE provides detailed images of the aorta and can quickly confirm the presence of an intimal flap, a characteristic finding in aortic dissection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">If the patient&nbsp;has been stable, then preferred investigation of choice is CT angiography.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. CXR PA view:</span></strong><span style=\"font-size:12.0pt\"> A chest X-ray (CXR) might show a widened mediastinum, which can be a clue to aortic dissection, but it is not definitive. It lacks the sensitivity and specificity needed for a rapid and accurate diagnosis in an emergency setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. MRI:</span></strong><span style=\"font-size:12.0pt\"> While MRI can provide excellent detail, it is not suitable for acutely unstable patients due to the time required for the scan and the need to transport the patient to the MRI suite. It is not practical in an emergency setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Troponin assay:</span></strong><span style=\"font-size:12.0pt\"> Troponin assays are used to diagnose myocardial infarction, not aortic dissection. Although troponins can be elevated in some cases of aortic dissection, they do not provide definitive diagnostic information about the dissection itself.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the setting of suspected aortic dissection, especially in an unstable patient, trans-esophageal echocardiography (TEE) is the best diagnostic tool due to its high sensitivity and ability to be performed at the bedside, providing rapid and accurate confirmation of the diagnosis.</span></span></p>",
      "correct_choice_id": 45203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20273,
      "choices": [
        {
          "id": 81053,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancoast tumor</span></span></span></p>"
        },
        {
          "id": 81054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Upper lobe pneumonia</span></span></span></p>"
        },
        {
          "id": 81055,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Superior vena cava obstruction</span></span></span></p>"
        },
        {
          "id": 81056,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspergilloma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old chronic smoker came to the medicine outpatient department with complaints of upper chest discomfort and drooping of an eyelid. He also complained of pain radiating to the upper arm and a tingling sensation in the 4th and 5th digits of his left hand. The chest X-ray is given below. What is the most likely diagnosis? (NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170545.jpg\" style=\"height:334px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6532495",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365479,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Pancoast tumor</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancoast tumors, also known as superior sulcus tumors, are a type of lung cancer located at the apex (top) of the lung. These tumors are particularly associated with several key clinical features and findings, especially in chronic smokers:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Upper chest discomfort</span></strong><span style=\"font-size:12.0pt\">: This is a common symptom of a Pancoast tumor due to the tumor&#39;s location at the apex of the lung.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drooping of an eyelid (ptosis)</span></strong><span style=\"font-size:12.0pt\">: This is part of Horner&#39;s syndrome, which occurs due to compression of the sympathetic nerves by the tumor. Horner&#39;s syndrome typically includes ptosis (drooping eyelid), miosis (constricted pupil), and anhidrosis (lack of sweating) on the affected side of the face.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pain radiating to the upper arm and tingling sensation</span></strong><span style=\"font-size:12.0pt\">: These symptoms suggest involvement of the brachial plexus, a network of nerves that supplies the arm and hand. Pancoast tumors often invade or compress these nerves, leading to referred pain and sensory disturbances in the arm and hand.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chest X-ray findings</span></strong><span style=\"font-size:12.0pt\">: The provided chest X-ray shows a mass at the apex of the lung, which is characteristic of a Pancoast tumor.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-31-114511.jpg\" style=\"height:306px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Upper lobe pneumonia</span></strong><span style=\"font-size:12.0pt\">: While upper lobe pneumonia can cause chest discomfort and possibly pain, it is not associated with Horner&#39;s syndrome or brachial plexus involvement. The X-ray findings would also typically show consolidation rather than a mass.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Superior vena cava obstruction</span></strong><span style=\"font-size:12.0pt\">: This condition can cause swelling and discoloration of the face, neck, and upper extremities due to impaired blood flow. However, it does not explain the specific nerve-related symptoms like Horner&#39;s syndrome or tingling in the digits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aspergilloma</span></strong><span style=\"font-size:12.0pt\">: Aspergillomas are fungal balls that develop in pre-existing lung cavities, usually in patients with a history of tuberculosis or other lung diseases. They do not typically present with the neurological symptoms seen in this case, nor do they commonly cause Horner&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancoast tumors, or superior sulcus tumors, are associated with upper chest discomfort, Horner&#39;s syndrome, and neurological symptoms in the arm due to their apical location and propensity to invade local structures such as the brachial plexus and sympathetic nerves.</span></span></p>",
      "correct_choice_id": 81053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11207,
      "choices": [
        {
          "id": 44794,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dubin-Johnson syndrome</span></span></span></span></p>"
        },
        {
          "id": 44795,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilson&#39;s disease</span></span></span></span></p>"
        },
        {
          "id": 44796,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menke&#39;s disease</span></span></span></span></p>"
        },
        {
          "id": 44797,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gilbert&#39;s syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low serum copper levels attributed to ATP7A gene is due to: (NEET PG 2018)</span></span></p>",
      "unique_key": "Q1427100",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365489,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Menke&rsquo;s disease</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menke&#39;s disease, also known as Menkes Kinky Hair syndrome, is caused by mutations in the <strong>ATP7A gene</strong>. This gene is crucial for the absorption and distribution of copper in the body. The mutation leads to reduced intestinal absorption of copper, resulting in low serum copper levels. This deficiency affects multiple systems, including neurodevelopment and connective tissue maintenance, often leading to severe developmental delay and life expectancy that rarely exceeds early childhood (Children die within 5 years). The condition is also associated with characteristic brittle, kinky hair, and growth retardation.</span></span></span></span></li>\r\n\t<li><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCC:</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CVS-Aneurysmal dissection/Cardiac rupture </span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-180518.jpg\" style=\"height:755px; width:706px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dubin-Johnson syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a liver disorder characterized by chronic jaundice and does not involve ATP7A or copper metabolism.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Wilson&#39;s disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although related to copper metabolism, Wilson&#39;s disease is due to mutations in the ATP7B gene, not ATP7A, leading to copper accumulation in tissues.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Gilbert&#39;s syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a common hereditary condition that affects bilirubin metabolism, unrelated to copper levels or ATP7A.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menke&#39;s disease is characterized by a genetic mutation in the ATP7A gene leading to poor copper absorption and severe systemic deficiencies, notable for its profound impact on early development and survival.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Chap 333.</span></span></strong></p>",
      "correct_choice_id": 44796,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66057,
      "choices": [
        {
          "id": 263377,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic stenosis</span></p>"
        },
        {
          "id": 263378,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic regurgitation</span></p>"
        },
        {
          "id": 263379,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic stenosis and aortic regurgitation</span></p>"
        },
        {
          "id": 263380,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral regurgitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pulsus bisferiens is seen in which of the following conditions? <i>(Twisted PYQ)</i></span><br>&nbsp;</p>",
      "unique_key": "Q8580063",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365459,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Aortic stenosis and aortic regurgitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pulsus bisferiens</strong> is characterized by a double systolic peak in the arterial pulse waveform. This finding is most commonly associated with:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Coexisting aortic stenosis and aortic regurgitation:</strong> The dual peak reflects the increased stroke volume and delayed ejection caused by these coexisting conditions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Isolated severe aortic regurgitation or hypertrophic cardiomyopathy (HCM):</strong> It can occasionally be observed in these conditions but is classically linked to the combination of aortic stenosis and regurgitation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic stenosis:</strong> Incorrect because aortic stenosis alone is associated with pulsus parvus et tardus ('small and slow pulse') due to obstruction across the aortic valve, not pulsus bisferiens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aortic regurgitation:</strong> Incorrect because isolated aortic regurgitation typically causes a water hammer pulse (Corrigan pulse) rather than pulsus bisferiens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mitral regurgitation:</strong> Incorrect because the pulse in mitral regurgitation is hyperkinetic due to increased left ventricular preload but does not exhibit a double systolic peak.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Pulsus bisferiens, characterized by a double systolic peak, is most commonly associated with the combination of aortic stenosis and aortic regurgitation. Recognizing this pulse helps clinicians in diagnosing and assessing complex valvular pathologies.</span></p>",
      "correct_choice_id": 263379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16170,
      "choices": [
        {
          "id": 64640,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Addison&#39;s disease</span></span></span></p>"
        },
        {
          "id": 64641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Renal artery stenosis</span></span></span></p>"
        },
        {
          "id": 64642,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pheochromocytoma</span></span></span></p>"
        },
        {
          "id": 64643,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperthyroidism</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presents with complaints of sudden onset headache, palpitations, and profuse sweating. The patient has had multiple similar episodes in the past. During these episodes, the patient&#39;s blood pressure is elevated. A 24-hour urinary metanephrine is elevated. What is the most likely diagnosis?</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q6587271",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365473,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) Pheochromocytoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pheochromocytoma is a rare tumor of the adrenal gland tissue. It results in the release of too much epinephrine and norepinephrine, hormones that control heart rate, metabolism, and blood pressure. The <strong>classic triad of symptoms</strong> includes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Headache</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Sudden and severe headaches.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Palpitations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rapid heart rate.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Profuse sweating</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Excessive sweating.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In addition to these symptoms, patients with pheochromocytoma often experience episodic hypertension (elevated blood pressure). The diagnosis is confirmed by measuring elevated levels of urinary metanephrine, a metabolite of catecholamines.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">TOC </span></strong><span style=\"font-size:12.0pt\">- </span><span style=\"font-size:12.0pt\">Start with an alpha blocker, after 24 to 48 hours, add a beta blocker. The </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">alpha blocker of choice is intravenous (IV) phentolamine</span><span style=\"font-size:12.0pt\">. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phenoxybenzamine or prazosin can be used as alternative alpha blockers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Addison&#39;s disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition results from adrenal insufficiency and typically presents with symptoms such as fatigue, weight loss, and hyperpigmentation. Hypotension (low blood pressure) is more common, rather than hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Renal artery stenosis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition can cause secondary hypertension, but it does not present with the classic triad of headache, palpitations, and sweating. Additionally, it would not typically elevate urinary metanephrine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hyperthyroidism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition can cause symptoms like palpitations and sweating, but it would not cause episodic hypertension or elevated urinary metanephrine levels. Instead, hyperthyroidism is more associated with a consistently high heart rate and other systemic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pheochromocytoma presents with the classic triad of headache, palpitations, and sweating, along with episodic hypertension and elevated urinary metanephrine levels.</span></span></span></p>",
      "correct_choice_id": 64642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47608,
      "choices": [
        {
          "id": 190043,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary embolism</span></p>"
        },
        {
          "id": 190044,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary edema</span></p>"
        },
        {
          "id": 190045,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral embolism</span></p>"
        },
        {
          "id": 190046,
          "text": "<p><span style=\"font-size:12.0pt;\">Paradoxical embolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A lady with mitral stenosis who is bedridden, develops sudden onset shortness of breath. On examination, she has a swollen red limb with pain in the calf. What is the clinical diagnosis?</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q7876339",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365505,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Pulmonary embolism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient, who is bedridden with mitral stenosis, presents with sudden onset shortness of breath and a swollen, red limb with calf pain. These clinical features strongly suggest deep vein thrombosis (DVT). The sudden shortness of breath indicates that a thrombus from the DVT has likely embolized to the lungs, causing a pulmonary embolism. This is a common and potentially life-threatening complication in bedridden patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pulmonary edema:&nbsp;</strong>This is characterized by fluid accumulation in the lungs, typically secondary to heart failure, and does not present with a swollen, red limb or calf pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cerebral embolism:&nbsp;</strong>This would present with neurological deficits, not shortness of breath and a swollen, red limb.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paradoxical embolism:&nbsp;</strong>This occurs when a thrombus passes from the venous to the arterial system through a cardiac shunt (e.g., patent foramen ovale). While this could be considered if there were signs of arterial embolism, the presentation here is more consistent with pulmonary embolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pulmonary embolism should be suspected in bedridden patients presenting with sudden onset shortness of breath and clinical signs of deep vein thrombosis, such as a swollen, red, painful limb.</span></p>",
      "correct_choice_id": 190043,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11269,
      "choices": [
        {
          "id": 45042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal dysmotility</span></span></span></span></p>"
        },
        {
          "id": 45043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myopathy</span></span></span></span></p>"
        },
        {
          "id": 45044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial lung disease</span></span></span></span></p>"
        },
        {
          "id": 45045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scleroderma renal crisis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is more common in limited cutaneous systemic sclerosis when compared to diffuse cutaneous systemic sclerosis? (NEET PG 2020)</span></span></p>",
      "unique_key": "Q2481241",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365452,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Esophageal dysmotility</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal dysmotility is more commonly associated with limited cutaneous systemic sclerosis (lcSSc), particularly as part of the CREST syndrome (Calcinosis, Raynaud&#39;s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia). This condition involves abnormalities in the motility of the esophagus, which can lead to difficulties in swallowing and gastroesophageal reflux.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Myopathy:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While myopathy can occur in systemic sclerosis, it is not specifically more common in limited cutaneous systemic sclerosis compared to the diffuse type.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Interstitial lung disease (ILD):</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> ILD is actually more commonly associated with diffuse cutaneous systemic sclerosis due to broader and more aggressive skin involvement and higher prevalence of specific autoantibodies like Anti-Scl-70 (anti-topoisomerase).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Scleroderma renal crisis:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a severe complication more frequently seen in diffuse cutaneous systemic sclerosis, particularly in the early stages of the disease, often exacerbated by the use of corticosteroids.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-191513.jpg\" style=\"height:588px; width:1000px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatology/ Chap 360</span></span></strong></span></span></p>",
      "correct_choice_id": 45042,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54264,
      "choices": [
        {
          "id": 216525,
          "text": "<p><span style=\"font-size:12.0pt;\">Ehlers-Danlos Syndrome</span></p>"
        },
        {
          "id": 216526,
          "text": "<p><span style=\"font-size:12.0pt;\">Marfan's Syndrome</span></p>"
        },
        {
          "id": 216527,
          "text": "<p><span style=\"font-size:12.0pt;\">Atherosclerosis</span></p>"
        },
        {
          "id": 216528,
          "text": "<p><span style=\"font-size:12.0pt;\">Scurvy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following connective tissue degradation disorder is associated with aortic aneurysm?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1616423",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365460,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Marfan's Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder that affects the body's connective tissues, which provide structural support to various organs and tissues. It is particularly associated with cardiovascular complications, including aortic aneurysms and dissections. This is due to the weakening of the aortic wall caused by defective fibrillin-1, a glycoprotein essential for the elasticity and strength of the connective tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Ehlers-Danlos Syndrome</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">While Ehlers-Danlos Syndrome (EDS) can lead to vascular complications, including aortic aneurysms, it is specifically the vascular type (Type IV) of EDS that is associated with these issues. However, Marfan's Syndrome is more commonly linked to aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Atherosclerosis</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Atherosclerosis is a condition characterized by the build-up of plaque within the arterial walls, leading to narrowing and hardening of the arteries. It is a risk factor for abdominal aortic aneurysm but is not classified as a connective tissue disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Scurvy</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Scurvy is caused by a deficiency in vitamin C, leading to defective collagen synthesis. While it results in symptoms like mucosal bleeding and poor wound healing, it is not associated with aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder closely associated with the development of aortic aneurysms due to the defective fibrillin-1 protein affecting the structural integrity of the aortic wall.</span></p>",
      "correct_choice_id": 216526,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47610,
      "choices": [
        {
          "id": 190051,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcus neoformans</span></p>"
        },
        {
          "id": 190052,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumocystis jirovecii</span></p>"
        },
        {
          "id": 190053,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
        },
        {
          "id": 190054,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumococcus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, normal glucose, increased protein and positive India ink staining. What is likely causative organism?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q8029478",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365480,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cryptococcus neoformans</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is Cryptococcus neoformans. The patient presents with signs of meningitis (fever, neck stiffness) and has a cerebrospinal fluid (CSF) profile showing lymphocytosis, normal glucose, increased protein, and positive India ink staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cryptococcal meningitis is a common opportunistic infection in HIV patients and is diagnosed by the presence of encapsulated yeast cells seen on India ink staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pneumocystis jirovecii:&nbsp;</strong>This organism typically causes pneumonia rather than meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tuberculosis:&nbsp;</strong>Tuberculous meningitis usually presents with low glucose levels in the CSF, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pneumococcus:&nbsp;</strong>Pneumococcal meningitis typically presents with a neutrophilic CSF rather than lymphocytic CSF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cryptococcus neoformans is a common cause of meningitis in HIV patients, characterized by lymphocytic CSF, normal glucose, increased protein, and positive India ink staining, which reveals encapsulated yeast cells. ​</span></p>",
      "correct_choice_id": 190051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47519,
      "choices": [
        {
          "id": 189687,
          "text": "<p><span style=\"font-size:12.0pt;\">15 mg</span></p>"
        },
        {
          "id": 189688,
          "text": "<p><span style=\"font-size:12.0pt;\">12 mg</span></p>"
        },
        {
          "id": 189689,
          "text": "<p><span style=\"font-size:12.0pt;\">8 mg</span></p>"
        },
        {
          "id": 189690,
          "text": "<p><span style=\"font-size:12.0pt;\">10 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male with an acute ischemic stroke is undergoing thrombolysis with IV alteplase. He currently weighs 80 kg. What is the appropriate dose of alteplase to be given to this patient?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q7372585",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365470,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 8 mg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The appropriate dose of IV alteplase (recombinant tissue plasminogen activator, rtPA) for a patient with acute ischemic stroke is 0.9 mg/kg. The total dose for an 80 kg patient would be approximately 72 mg (0.9 mg/kg x 80 kg = 72 mg). According to the standard administration protocol:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">10% of the total dose is given as an initial bolus over 1 minute.</span></li><li><span style=\"font-size:12.0pt;\">The remaining 90% is infused over 1 hour.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For this patient:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Total dose = 72 mg.</span></li><li><span style=\"font-size:12.0pt;\">Bolus dose = 10% of 72 mg = 7.2 mg, rounded to 8 mg.</span></li><li><span style=\"font-size:12.0pt;\">The remaining dose (64.8 mg ≈ 64 mg) is given as a continuous infusion over 1 hour.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, the initial bolus dose of alteplase for this patient is 8 mg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient weighing 80 kg, the appropriate initial bolus dose of alteplase for acute ischemic stroke is 8 mg, followed by the remainder of the dose given as an infusion over 1 hour.</span></p>",
      "correct_choice_id": 189689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11596,
      "choices": [
        {
          "id": 46350,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amphotericin B</span></span></span></p>"
        },
        {
          "id": 46351,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>"
        },
        {
          "id": 46352,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone</span></span></span></p>"
        },
        {
          "id": 46353,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A person presents to the hospital with fever and chills. Fever profile is ordered and is found to be negative for malaria and dengue. RK-39 test is found to be positive. What is the treatment of choice?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q1006239",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365493,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Amphotericin B</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The RK-39 test is used to diagnose visceral leishmaniasis, which is also known as kala-azar. Visceral leishmaniasis is caused by the Leishmania parasite and is transmitted by the bite of infected sandflies. The test detects antibodies against the RK-39 antigen, which is a marker for this disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In India, the first-line treatment for visceral leishmaniasis is Amphotericin B. This drug is effective in treating the disease and is preferred due to its ability to clear the infection. While other treatments like sodium stibogluconate are available, Amphotericin B is the standard treatment due to its efficacy and safety profile in the Indian context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Griseofulvin</strong>: This is an antifungal medication used to treat dermatophyte infections of the skin, hair, and nails. It is not effective against parasitic infections like leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Dapsone</strong>: This drug is primarily used to treat leprosy and certain types of dermatitis. It is not used for treating leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Hydroxychloroquine</strong>: This medication is used for the treatment of malaria, rheumatoid arthritis, and lupus erythematosus. It is not effective against leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The RK-39 test is used to diagnose visceral leishmaniasis, and the treatment of choice for visceral leishmaniasis in India is Amphotericin B</span></span></span></p>",
      "correct_choice_id": 46350,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11352,
      "choices": [
        {
          "id": 45374,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous salbutamol</span></span></span></p>"
        },
        {
          "id": 45375,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous nitroglycerin</span></span></span></p>"
        },
        {
          "id": 45376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nebulization with salbutamol</span></span></span></p>"
        },
        {
          "id": 45377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxygen and antibiotics</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A hypertensive patient who is non-compliant with medication presents to you with sudden onset breathlessness. A chest X-ray was done, which is shown below. How will you manage this patient? (Neet pg 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191623.jpg\" style=\"height:305px; width:400px\" /></p>",
      "unique_key": "Q1210870",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365494,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Intravenous nitroglycerin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with symptoms and signs indicative of pulmonary edema, which is evident from the chest X-ray showing interstitial edema and classic bat-wing appearance, suggestive of cardiogenic pulmonary edema. The history of hypertension and non-compliance with medication supports the diagnosis, as poorly controlled hypertension can lead to increased afterload, left ventricular failure, and subsequent pulmonary edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intravenous nitroglycerin</span></strong><span style=\"font-size:12.0pt\">: Nitroglycerin is the treatment of choice in this scenario as it helps to reduce both preload and afterload by dilating veins and arteries. This leads to a reduction in pulmonary congestion and improvement in symptoms of breathlessness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intravenous salbutamol</span></strong><span style=\"font-size:12.0pt\">: Salbutamol is a bronchodilator used primarily in the treatment of asthma or COPD exacerbations, and primarily not used intravenously. It is not indicated for managing pulmonary edema and does not address the underlying cause of fluid accumulation in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nebulization with salbutamol</span></strong><span style=\"font-size:12.0pt\">: Similar to intravenous salbutamol, nebulized salbutamol is used for bronchodilation in conditions like asthma or COPD. It is not effective in treating pulmonary edema and does not relieve the symptoms caused by fluid overload in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oxygen and antibiotics</span></strong><span style=\"font-size:12.0pt\">: While oxygen might be necessary to support the patient&rsquo;s respiratory status, antibiotics are not indicated unless there is a concurrent infection, which is not suggested by the patient&rsquo;s presentation. The primary issue here is fluid overload due to heart failure, not an infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of cardiogenic pulmonary edema, intravenous nitroglycerin is essential to reduce preload and afterload, thereby alleviating pulmonary congestion and improving the patient&#39;s symptoms.</span></span></p>",
      "correct_choice_id": 45375,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55353,
      "choices": [
        {
          "id": 220873,
          "text": "<p><span style=\"font-size:12pt;\">Transposition of great vessels</span></p>"
        },
        {
          "id": 220874,
          "text": "<p><span style=\"font-size:12pt;\">Coarctation of Aorta</span></p>"
        },
        {
          "id": 220875,
          "text": "<p><span style=\"font-size:12pt;\">Tetralogy of Fallot</span></p>"
        },
        {
          "id": 220876,
          "text": "<p><span style=\"font-size:12pt;\">Ebstein’s anomaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient presented with strong upper limb pulses and weak lower limb pulses with chest x-ray showing rib notching. What is the diagnosis?<strong> </strong>(FMGE JULY 2024)</span></p>",
      "unique_key": "Q9172244",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365484,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coarctation of Aorta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The classic presentation of coarctation of the aorta, a congenital condition characterized by the narrowing of the aorta. This narrowing typically occurs just after the arteries that branch off to the upper body, leading to a disparity in blood flow and pressure between the upper and lower parts of the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Key indicators in this case include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Strong upper limb pulses and weak lower limb pulses:</strong> The narrowing restricts blood flow to the lower extremities, causing the upper body to receive a higher volume of blood, which results in stronger pulses in the upper limbs compared to the lower limbs.</span></li><li><span style=\"font-size:12pt;\"><strong>Chest x-ray showing rib notching:</strong> Rib notching is a result of enlarged intercostal arteries that form collateral pathways to bypass the narrowed aorta. These arteries erode the underside of the ribs over time, creating a notched appearance on chest x-rays.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Transposition of great vessels:</strong> This condition involves the switching of the major arteries (the aorta and the pulmonary artery) from their normal positions. It does not present with rib notching or a difference in pulse strength between the upper and lower limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tetralogy of Fallot:</strong> This is a combination of four heart defects, including a ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy, and an overriding aorta. It primarily presents with cyanosis and does not typically involve rib notching or differential limb pulses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ebstein’s anomaly:</strong> This is a rare heart defect affecting the tricuspid valve and right ventricle. It does not cause rib notching or a significant difference in pulse strength between upper and lower limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Coarctation of the aorta is identified by the presence of strong upper limb pulses, weak lower limb pulses, and rib notching on a chest x-ray, which is caused by collateral circulation developing around the narrowed section of the aorta.</span></p>",
      "correct_choice_id": 220874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11757,
      "choices": [
        {
          "id": 46994,
          "text": "<p><span style=\"font-size:12.0pt;\">PCl</span></p>"
        },
        {
          "id": 46995,
          "text": "<p><span style=\"font-size:12.0pt;\">Prophylaxis for arrhythmia</span></p>"
        },
        {
          "id": 46996,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombolysis with alteplase</span></p>"
        },
        {
          "id": 46997,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin with heparin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes to the hospital within 3 hours of the onset of chest pain. ECG revealed ST depression in anterior chest leads and T wave inversion. She could be best managed by? (INICET NOV 2020)</span></p>",
      "unique_key": "Q6312545",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365498,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Aspirin with heparin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The description of diffuse symmetric TWI without ST elevations is consistent with NSTEMI which is characterized by subtotal platelet-rich thrombosis + distal phasic embolization. NSTEMI treated with DAPT+LMWH followed by CAG for risk stratification</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>PCI is treatment of choice for STEMI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Arrhythmia prophylaxis is not the definitive best management strategy</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Thrombolysis/Fibrinolytics have no role in the management of NSTEMI</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105103.png\" alt=\"\" width=\"1000\" height=\"848\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology/ACS/Chap 277</strong></span></p>",
      "correct_choice_id": 46997,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20262,
      "choices": [
        {
          "id": 81009,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamivudine</span></p>"
        },
        {
          "id": 81010,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenofovir</span></p>"
        },
        {
          "id": 81011,
          "text": "<p><span style=\"font-size:12.0pt;\">Peg IFN for 52 weeks</span></p>"
        },
        {
          "id": 81012,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined peg IFN with lamivudine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male is found to be positive for HBsAg and HBeAg and is diagnosed with chronic hepatitis B. The viral load of the patient was 2 x 10^5 IU/mL and ALT is found to be doubled. What is the appropriate management? (NEET PG 2023)</span></p>",
      "unique_key": "Q4233835",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365471,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tenofovir</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is diagnosed with chronic hepatitis B, as indicated by the positive HBsAg and HBeAg, which are markers of infection and infectivity, respectively. The viral load of 2 x 10<sup>5</sup> IU/mL and elevated ALT levels suggest active viral replication and liver inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBsAg (Hepatitis B surface antigen)</strong>: This is a marker of infection. Its presence indicates that the person is infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBeAg (Hepatitis B e antigen)</strong>: This is a marker of infectivity. It indicates that the virus is replicating and the patient is highly infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBV DNA</strong>: This is a marker of viral replication. In chronic hepatitis B, a high level of HBV DNA correlates with an increased risk of complications such as cirrhosis and hepatocellular carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The decision to start treatment in chronic hepatitis B is primarily based on the levels of HBV DNA and ALT. According to guidelines, treatment is indicated if:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HBV DNA is more than 2000 IU/mL.</span></li><li><span style=\"font-size:12.0pt;\">ALT is elevated (more than 2 to 3 times the upper limit of normal).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this patient, both criteria are met.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tenofovir</strong> is preferred for its efficacy and lower risk of resistance compared to other options like lamivudine. Tenofovir is also favored over interferon-based therapies due to better durability of response and lower side effect profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lamivudine</strong>: This drug is no longer preferred due to a high risk of resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Peg IFN for 52 weeks</strong>: Pegylated interferon is not preferred due to less favorable response rates and a higher side effect profile compared to tenofovir.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Combined peg IFN with lamivudine</strong>: Combination therapy with pegylated interferon and lamivudine is not recommended due to increased side effects and no significant improvement in efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tenofovir is the preferred treatment for chronic hepatitis B with high viral load and elevated ALT levels due to its efficacy and lower risk of resistance.</strong></span></p>",
      "correct_choice_id": 81010,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54261,
      "choices": [
        {
          "id": 216513,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true and reason is the correct explanation of assertion</span></span></p>"
        },
        {
          "id": 216514,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true but reason is not the correct explanation of assertion</span></span></p>"
        },
        {
          "id": 216515,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is true, reason is false</span></span></p>"
        },
        {
          "id": 216516,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is false, reason is true</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Assertion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Myocarditis is seen as a complication of diphtheria.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Reason</strong>: It is due to bacteremia.&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1669572",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) Assertion is true, reason is false</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The assertion that myocarditis is seen as a complication of diphtheria is correct. Myocarditis is a well-known and serious complication of diphtheria, often leading to significant morbidity and mortality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The reason provided, that myocarditis is due to bacteremia, is incorrect. The complications of diphtheria, including myocarditis, are primarily due to the effects of the diphtheria toxin (toxemia), not bacteremia. The toxin affects various organs, including the heart, leading to myocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myocarditis is a complication of diphtheria caused by the diphtheria toxin (toxemia), not by bacteremia.</span></span></span></p>",
      "correct_choice_id": 216515,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49326,
      "choices": [
        {
          "id": 196871,
          "text": "<p><span style=\"font-size:12.0pt;\">Lichtenstein operation</span></p>"
        },
        {
          "id": 196872,
          "text": "<p><span style=\"font-size:12.0pt;\">Shouldice operation</span></p>"
        },
        {
          "id": 196873,
          "text": "<p><span style=\"font-size:12.0pt;\">Stoppa operation</span></p>"
        },
        {
          "id": 196874,
          "text": "<p><span style=\"font-size:12.0pt;\">Bassini repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">The four-layer suture repair of an inguinal hernia with double breasting of the posterior wall of the inguinal canal is known as: (NEET PG 2015)</span></p>",
      "unique_key": "Q5353902",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365477,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><strong>Correct Answer: B. Shouldice operation</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>The Shouldice operation is specifically characterized as a four-layer herniorrhaphy technique that involves double breasting of the conjoint tendon, inguinal ligament, and the two halves of the fascia transversalis to create a reinforced posterior wall repair. This multi-layered approach creates a strong repair using local tissues without mesh.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul><li><strong>Option A. Lichtenstein operation</strong>: This is a tension-free hernioplasty that uses a polypropylene mesh placed on top of the posterior wall (onlay repair). It does not involve double breasting of local tissues or a four-layer repair.</li><li><strong>Option C. Stoppa operation</strong>: This is a preperitoneal mesh repair technique primarily used for complex or recurrent hernias. It involves placing a large mesh in the preperitoneal space, not a four-layer tissue repair.</li><li><strong>Option D. Bassini repair</strong>: While this is also a herniorrhaphy technique, it involves suturing the conjoint tendon to the inguinal ligament using interrupted sutures. It does not include the four-layer double breasting technique that defines the Shouldice repair.</li></ul><p>&nbsp;</p><p><strong>Comparison of hernia repair techniques:</strong></p><ul><li><strong>Herniorrhaphy</strong>: Strengthening of the posterior wall using locally available tissue&nbsp;<ul style=\"list-style-type:circle;\"><li>Bassini: Simple suturing of conjoint tendon to inguinal ligament</li><li>Shouldice: Double-breasting with 4-layer posterior wall repair</li><li>Desarda: Uses a strip of external oblique aponeurosis</li></ul></li><li><strong>Hernioplasty</strong>: Use of prosthetic material (mesh)&nbsp;<ul style=\"list-style-type:circle;\"><li>Lichtenstein: Onlay mesh repair</li></ul></li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>The Shouldice repair is distinguished by its meticulous four-layer closure technique with double-breasting of the posterior wall tissues, creating a strong anatomical repair without the use of prosthetic material.</p>",
      "correct_choice_id": 196872,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11312,
      "choices": [
        {
          "id": 45214,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase Aspirin dose</span></span></p>"
        },
        {
          "id": 45215,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase atenolol dose</span></span></p>"
        },
        {
          "id": 45216,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add a Long-Acting Nitrate</span></span></p>"
        },
        {
          "id": 45217,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add P2Y12 receptor inhibitor</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 54-year-old woman presented with chest pain. In an angiogram, her left circumflex artery was found to be stenosed, and a stent was inserted. Her current medications include ASA 75mg OD, atenolol 50mg BID, lovastatin, and lisinopril. What should be done in this scenario?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q1953909",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365478,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Add P2Y12 receptor inhibitor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After stent placement, it is crucial to prevent stent thrombosis, which can be life-threatening. Dual antiplatelet therapy (DAPT) is the standard of care in this scenario. DAPT includes aspirin and a P2Y12 receptor inhibitor (such as clopidogrel, prasugrel, or ticagrelor). These medications work synergistically to inhibit platelet aggregation and prevent thrombus formation within the stent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is already on aspirin 75 mg daily, so the addition of a P2Y12 receptor inhibitor is necessary to complete the DAPT regimen. This combination has been shown to significantly reduce the risk of stent thrombosis and other cardiovascular events after percutaneous coronary intervention (PCI) with stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Guidelines on the duration of dual antiplatelet therapy (DAPT) &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug-Eluting Stents (DES)</span></strong><span style=\"font-size:12.0pt\">: A minimum of 6 months of DAPT is recommended. This therapy usually involves the use of aspirin combined with a P2Y12 receptor inhibitor (such as clopidogrel, ticagrelor, or prasugrel) to prevent clot formation around the new stent.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bare Metal Stents (BMS)</span></strong><span style=\"font-size:12.0pt\">: At least 1 month of DAPT is required. Although the duration is shorter than that for DES, it&#39;s crucial for preventing early stent thrombosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Stents Inserted for Acute Coronary Syndrome (ACS)</span></strong><span style=\"font-size:12.0pt\">: If a stent is inserted as part of treatment for ACS, the recommended minimum duration of DAPT extends to 12 months. This extended period helps manage the higher risk of thrombosis and other complications associated with ACS.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Current Patient Situation</span></strong><span style=\"font-size:12.0pt\">: <strong>Ongoing Medication</strong>: The patient is already on aspirin. A P2Y12 receptor inhibitor needs to be added to the regimen to complete the DAPT, ensuring optimal protection against clotting.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increase Aspirin dose:</span></strong><span style=\"font-size:12.0pt\"> Increasing the aspirin dose does not provide additional benefit in preventing stent thrombosis and is not recommended as part of DAPT. The current dose of 75 mg is adequate when combined with a P2Y12 receptor inhibitor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increase atenolol dose:</span></strong><span style=\"font-size:12.0pt\"> Atenolol, a beta-blocker, is used for managing hypertension and angina but does not prevent stent thrombosis. Increasing its dose does not address the immediate need for antiplatelet therapy post-stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Add a Long-Acting Nitrate:</span></strong><span style=\"font-size:12.0pt\"> Long-acting nitrates can help manage angina symptoms but do not prevent stent thrombosis. They are not part of the recommended therapy to prevent thrombotic complications after stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After stent placement, dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor (such as clopidogrel, prasugrel, or ticagrelor) is essential to prevent stent thrombosis and ensure optimal patient outcomes.</span></span></p>",
      "correct_choice_id": 45217,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11546,
      "choices": [
        {
          "id": 46150,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 46151,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 46152,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4 and 5</span></p>"
        },
        {
          "id": 46153,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During the discharge of a COVID patient who was treated with steroids and remdesivir, which of the following will you inform him about? (INICET MAY 2021)</span></p><p>&nbsp;</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Repeat RT-PCR after 7 days of discharge</span></li><li><span style=\"font-size:12.0pt;\">Watch for the persistence of Anosmia</span></li><li><span style=\"font-size:12.0pt;\">Watch for Headache and nasal discharge</span></li><li><span style=\"font-size:12.0pt;\">Monitor glucose levels</span></li><li><span style=\"font-size:12.0pt;\">Watch for Sinusitis-like symptoms</span></li></ol>",
      "unique_key": "Q8133458",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365466,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) 3, 4 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Discharging a COVID-19 patient involves providing instructions for monitoring ongoing or potential symptoms and managing side effects of treatments such as steroids and remdesivir.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Watch for headache and nasal discharge:</strong> These symptoms can be part of the post-COVID syndrome or could indicate secondary infections like sinusitis, especially after treatment that might suppress the immune system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Monitor glucose levels:</strong> Steroids, often used in the treatment of severe COVID-19, can elevate blood glucose levels. It’s crucial for patients, especially those with pre-existing diabetes or those who experienced high glucose levels during treatment, to monitor their levels after discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>5. Watch for sinusitis-like symptoms:</strong> As with headache and nasal discharge, symptoms like those of sinusitis might suggest secondary infections, which are important to monitor given the use of immunomodulating treatments like steroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Repeat RT-PCR after 7 days of discharge:&nbsp;</strong>Repeat RT-PCR after 7 days of discharge is not required as per updated guidelines<strong>.</strong> Repeat RT-PCR at 7 days of discharge was&nbsp;initially suggested, but later on removed from the guideline.&nbsp;</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Watch for the persistence of Anosmia:&nbsp;</strong>Watch for the persistence of Anosmia is a common symptom (Anosmia can persist for weeks together) but, not matching with the options (actual answer should be 2,3,4, and 5).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Patients recovering from COVID-19 should monitor for symptoms of headache and nasal discharge, glucose levels due to steroid use, and sinusitis-like symptoms which could indicate secondary infections like mucormycosis.</span></p>",
      "correct_choice_id": 46152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47520,
      "choices": [
        {
          "id": 189691,
          "text": "<p><span style=\"font-size:12.0pt;\">Parkinson's disease</span></p>"
        },
        {
          "id": 189692,
          "text": "<p><span style=\"font-size:12.0pt;\">Huntington's chorea</span></p>"
        },
        {
          "id": 189693,
          "text": "<p><span style=\"font-size:12.0pt;\">Friedreich's ataxia</span></p>"
        },
        {
          "id": 189694,
          "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents with complaints of sudden, involuntary, and uncontrollable dance-like movements. He also complains of facing difficulty with his memory. His wife says he has gotten very emotional recently. What is the most likely diagnosis?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q6771828",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365468,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Huntington's chorea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient presents with the classic triad of symptoms seen in Huntington's disease:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hyperkinetic movements (Chorea):&nbsp;</strong>Sudden, involuntary, and uncontrollable dance-like movements are characteristic of chorea, a key feature of Huntington's disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cognitive decline (Dementia):&nbsp;</strong>The patient has memory problems, which aligns with the cognitive decline seen in Huntington's disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Psychiatric manifestations:&nbsp;</strong>Emotional lability, as noted by the patient's wife, is common in Huntington's disease and can include depression, irritability, and other mood disturbances.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Huntington's disease is an inherited condition characterized by progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Parkinson's disease:&nbsp;</strong>This condition typically presents with hypokinetic symptoms such as bradykinesia, rigidity, and resting tremor, which do not match the hyperkinetic movements described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Friedreich's ataxia:&nbsp;</strong>This condition usually presents in younger individuals (typically diagnosed by 15-20 years of age) with symptoms of ataxia and sensory loss. The patient in this case does not exhibit ataxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alzheimer's disease:&nbsp;</strong>Alzheimer's typically presents with progressive memory loss and cognitive decline in older adults (65-70+ years). It does not include hyperkinetic movements, making it an unlikely diagnosis for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Huntington's disease is characterized by a triad of hyperkinetic movements (chorea), cognitive decline (dementia), and psychiatric symptoms, fitting the patient's presentation.</span></p>",
      "correct_choice_id": 189692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11722,
      "choices": [
        {
          "id": 46854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV calcium</span></span></span></span></p>"
        },
        {
          "id": 46855,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC Shock</span></span></span></span></p>"
        },
        {
          "id": 46856,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV MgS04</span></span></span></span></p>"
        },
        {
          "id": 46857,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ECG of a pregnant lady having pre-eclampsia is shown below. Her vitals are stable. What is the best step in the management of the condition?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Aptos&quot;,sans-serif\"> (AIIMS NOV 2019)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm123.jpg\" style=\"height:337px; width:600px\" /></span></span></span></span></p>",
      "unique_key": "Q7947414",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365492,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV MgSO4</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ECG displays characteristics consistent with Torsades de Pointes (Tdp), which is identified by its distinctive polymorphic ventricular tachycardia and a prolonged QT interval. In the setting of pre-eclampsia, magnesium sulfate (MgSO4) is not only used for seizure prophylaxis but also effectively treats Torsades de Pointes by stabilizing the cardiac membrane and correcting magnesium deficiency, a common trigger for this arrhythmia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IV calcium:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used for treating hyperkalemia or hypocalcemia-induced cardiac toxicity, not directly effective for Torsades de Pointes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. DC Shock:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indicated for hemodynamically unstable patients with Tdp or other life-threatening arrhythmias, which does not apply here as the patient&#39;s vitals are stable.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Synchronized cardioversion:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically used for managing ventricular tachycardia with a pulse or superventricular tachycardia, but not the first-line for Torsades de Pointes in a stable patient.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a stable pregnant patient displaying Torsades de Pointes, especially in the context of pre-eclampsia, IV magnesium sulfate is the recommended treatment. It helps in both controlling the arrhythmia and providing prophylaxis against eclamptic seizures.</span></span></p>",
      "correct_choice_id": 46856,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47611,
      "choices": [
        {
          "id": 190055,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 190056,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        },
        {
          "id": 190057,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        },
        {
          "id": 190058,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2 month pregnant female presents with swelling in legs and diagnosed with Deep vein thrombosis, she requires anticoagulation. Which of the following is Preferred?</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q2740727",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365508,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Enoxaparin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnant women diagnosed with deep vein thrombosis (DVT), low molecular weight heparin (LMWH) such as enoxaparin is the preferred anticoagulant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LMWH is effective and has a better safety profile for both the mother and the fetus compared to other anticoagulants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is teratogenic and contraindicated in pregnancy, particularly in the first trimester. Direct oral anticoagulants (DOACs) like apixaban are not recommended during pregnancy due to insufficient safety data. Aspirin alone is not effective for treating DVT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Warfarin:&nbsp;</strong>This is contraindicated during pregnancy due to its teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apixaban:&nbsp;</strong>DOACs are not approved for use in pregnant or lactating women due to a lack of sufficient safety data.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aspirin:&nbsp;</strong>While it may be used for certain cardiovascular conditions, it is not effective as a sole agent for the treatment of DVT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Enoxaparin (LMWH) is the preferred anticoagulant for pregnant women with DVT due to its safety and effectiveness, whereas warfarin, DOACs, and aspirin are not appropriate choices in this context.</span></p>",
      "correct_choice_id": 190057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11310,
      "choices": [
        {
          "id": 45206,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triamterene</span></span></p>"
        },
        {
          "id": 45207,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KCl</span></span></p>"
        },
        {
          "id": 45208,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></p>"
        },
        {
          "id": 45209,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 55-year-old man presented with cough and congestion in the chest. He is a known case of atrial fibrillation (AF) and on examination, he had an irregularly irregular pulse and ECG showed AF with a heart rate of 52/min. His current medications are KCl 10 mEq BID, Triamterene, ASA 100mg/day, Atenolol 50 mg BID, and Clarithromycin. Two months ago, his digoxin levels were 1.5 ng/mL and currently, it rose to 3.4 ng/mL. Which of the following is responsible for such an increase in digoxin levels?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q8044888",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365476,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Clarithromycin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is experiencing elevated digoxin levels, which is likely due to a drug-drug interaction. Digoxin is a medication used to treat various heart conditions, including atrial fibrillation. It has a narrow therapeutic index, meaning that even small changes in its levels can lead to toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clarithromycin is a macrolide antibiotic that inhibits the enzyme cytochrome P450 3A4 (CYP3A4). Digoxin is partially metabolized by CYP3A4. When clarithromycin inhibits this enzyme, it can lead to decreased metabolism of digoxin, resulting in elevated digoxin levels and potential toxicity. This interaction can explain the significant increase in the patient&#39;s digoxin levels from 1.5 ng/mL to 3.4 ng/mL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Triamterene:</span></strong><span style=\"font-size:12.0pt\"> Triamterene is a potassium-sparing diuretic and does not typically interact with digoxin in a way that would cause elevated digoxin levels. It is not known to inhibit the metabolism of digoxin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. KCl:</span></strong><span style=\"font-size:12.0pt\"> Potassium chloride (KCl) supplementation is often given to prevent hypokalemia, which can enhance the toxic effects of digoxin. However, KCl does not directly interact with digoxin to increase its serum levels. Instead, it helps mitigate digoxin toxicity by maintaining normal potassium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Atenolol:</span></strong><span style=\"font-size:12.0pt\"> Atenolol is a beta-blocker and does not interact with digoxin to increase its serum levels. While it can affect heart rate, it does not interfere with the metabolism or excretion of digoxin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin, by inhibiting CYP3A4, can significantly elevate digoxin levels, leading to toxicity. When prescribing medications, it is essential to consider potential drug-drug interactions, especially with drugs like digoxin that have a narrow therapeutic index.</span></span></p>",
      "correct_choice_id": 45208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45565,
      "choices": [
        {
          "id": 181899,
          "text": "<p><span style=\"font-size:14.0pt;\">21 days</span></p>"
        },
        {
          "id": 181900,
          "text": "<p><span style=\"font-size:14.0pt;\">30 days</span></p>"
        },
        {
          "id": 181901,
          "text": "<p><span style=\"font-size:14.0pt;\">35 days</span></p>"
        },
        {
          "id": 181902,
          "text": "<p><span style=\"font-size:14.0pt;\">42 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Shelf life of blood in a blood bank in CPDA buffer? (NEET PG 2014)</span></p>",
      "unique_key": "Q2353852",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365509,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. 35 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The FDA-approved shelf life of blood stored in CPDA-1 (Citrate-Phosphate-Dextrose with Adenine) buffer is 35 days. This buffer is one of the standard anticoagulant-preservative solutions used in clinical practice. The shelf life or expiration date is determined by the number of red blood cells (RBCs) that survive in the circulation 24 hours after transfusion. A minimum of 70% of stored RBCs must survive in the first 24 hours for the blood to be considered viable.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Shelf Life of Blood in Different Buffers:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/26/screenshot-2024-05-26-064107_Yv4waQT.jpg\" alt=\"\" width=\"1000\" height=\"369\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. 21 days</strong>: This is the shelf life for blood stored in ACD, CPD, or CP2D buffers.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. 30 days:</strong> There is no buffer with a standard shelf life of 30 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. 42 days:</strong> This is the shelf life for blood stored in certain additive solutions, not CPDA-1.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The shelf life of blood stored in CPDA-1 buffer is 35 days.</span></p>",
      "correct_choice_id": 181901,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55354,
      "choices": [
        {
          "id": 220877,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metabolic acidosis</span></span></p>"
        },
        {
          "id": 220878,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metabolic alkalosis</span></span></p>"
        },
        {
          "id": 220879,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Respiratory acidosis</span></span></p>"
        },
        {
          "id": 220880,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Respiratory alkalosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following best describes the ABG findings: (FMGE JULY 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">pH &ndash; 7.28,</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PaCO2 &ndash; 28 mm Hg, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PaO2 &ndash; 98 mm Hg, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Na &ndash; 140 mEq/L, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">K &ndash; 4.9 mEq/L, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HCO3 &ndash; 14 mEq/L, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cl &ndash; 100 mEq/L.</span></span></p>",
      "unique_key": "Q3757116",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365485,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Metabolic acidosis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The ABG (arterial blood gas) findings indicate a pH of 7.28, which is below the normal range (7.35-7.45), indicating acidosis. Both PaCO2 and HCO3 are low, which suggests a primary metabolic issue. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">According to the <strong>mnemonic &quot;ROME&quot; (Respiratory Opposite, Metabolic Equal),</strong> in metabolic disorders, the pH and bicarbonate move in the same direction. Here, both pH and HCO3 are low, confirming metabolic acidosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Additionally, calculating the anion gap helps further classify the metabolic acidosis. The anion gap is calculated as Na - (HCO3 + Cl) = 140 - (14 + 100) = 26, which is above the normal range (8-12 mEq/L), indicating a high anion gap metabolic acidosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Metabolic alkalosis: </strong>This condition is characterized by an increased pH (alkalosis) and increased HCO3. The patient&#39;s pH is low, not high, ruling out metabolic alkalosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Respiratory acidosis: </strong>This condition is characterized by a decreased pH (acidosis) and increased PaCO2 due to hypoventilation. The patient&#39;s PaCO2 is low, not high, ruling out respiratory acidosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Respiratory alkalosis: </strong>This condition is characterized by an increased pH (alkalosis) and decreased PaCO2 due to hyperventilation. The patient&#39;s pH is low, indicating acidosis, not alkalosis, ruling out respiratory alkalosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metabolic acidosis is indicated by a low pH and low HCO3, with the same direction of changes in both parameters. A high anion gap indicates the presence of unmeasured anions, often seen in conditions like diabetic ketoacidosis, lactic acidosis, and renal failure.</span></span></p>",
      "correct_choice_id": 220877,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47609,
      "choices": [
        {
          "id": 190047,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac Tamponade</span></p>"
        },
        {
          "id": 190048,
          "text": "<p><span style=\"font-size:12.0pt;\">Status Asthmaticus</span></p>"
        },
        {
          "id": 190049,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophic Cardiomyopathy</span></p>"
        },
        {
          "id": 190050,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension Pneumothorax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient had a drop in Systolic Blood Pressure of 15 mm Hg during inspiration. Which of the following is NOT associated with it?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q6591501",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365506,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hypertrophic Cardiomyopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A drop in systolic blood pressure of more than 10 mm Hg during inspiration is termed <strong>pulsus paradoxus.</strong> This phenomenon is seen in several conditions, including <strong>cardiac tamponade, status asthmaticus, and tension pneumothorax.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cardiac tamponade is a classic cause of pulsus paradoxus due to the restriction of ventricular filling during inspiration. Status asthmaticus and tension pneumothorax also cause significant intrathoracic pressure changes, leading to a similar hemodynamic effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypertrophic cardiomyopathy, on the other hand, is not associated with pulsus paradoxus. Instead, HCM can be associated with pulsus bisferiens, a double-peaked pulse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cardiac Tamponade:&nbsp;</strong>This is a well-known cause of pulsus paradoxus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Status Asthmaticus:&nbsp;</strong>This can cause pulsus paradoxus due to severe obstruction and changes in intrathoracic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tension Pneumothorax:&nbsp;</strong>This condition can also lead to pulsus paradoxus due to significant intrathoracic pressure changes.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pulsus paradoxus, a significant drop in systolic blood pressure during inspiration, is seen in conditions like cardiac tamponade, status asthmaticus, and tension pneumothorax. It is not associated with hypertrophic cardiomyopathy, which can present with pulsus bisferiens instead.</span></p>",
      "correct_choice_id": 190049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11402,
      "choices": [
        {
          "id": 45574,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hypersecreting adenoma</span></p>"
        },
        {
          "id": 45575,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Papillary carcinoma thyroid</span></p>"
        },
        {
          "id": 45576,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Grave’s disease</span></p>"
        },
        {
          "id": 45577,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Lateral aberrant thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Below is a radioactive scan for thyroid pathology. which of the following is the most probable diagnosis: (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm56.jpg\" alt=\"\" width=\"300\" height=\"256\"></span></p>",
      "unique_key": "Q3881893",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365458,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hypersecreting Adenoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image findings are suggestive of hypersecreting adenoma.</span></p><p>&nbsp;</p><ol><li><span style=\"color:black;font-size:12.0pt;\">Increased uptake in the right lobe at the thyroid</span></li><li><span style=\"color:black;font-size:12.0pt;\">Suppressed uptake in left lobe of thyroid</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These findings are highly suggestive of a hypersecreting adenoma. This condition occurs when a benign tumor in the thyroid gland produces thyroid hormone independently of the normal regulatory mechanisms, leading to an overactive area (hot spot) in one part of the thyroid, with suppression of activity in the rest of the gland due to negative feedback mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Papillary carcinoma of the thyroid:</strong> Incorrect as this type of cancer typically presents with a \"cold nodule,\" which shows reduced or no uptake on a radioactive scan. The scan shows no areas of reduced uptake indicative of a cold nodule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Grave’s disease:</strong> Incorrect because Grave's disease generally causes a diffuse increase in uptake across the entire thyroid gland due to widespread stimulation of thyroid tissue. The scan does not show diffuse uptake, which rules out Grave's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lateral aberrant thyroid:</strong> Incorrect as this condition involves ectopic thyroid tissue that might appear as functioning thyroid tissue outside the normal location. The scan does not indicate any ectopic thyroid tissue.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypersecreting adenoma in the thyroid is characterized by increased radioactive uptake in one area of the thyroid with suppression in other areas, reflecting independent hormone production from the adenoma.</span></p>",
      "correct_choice_id": 45574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11702,
      "choices": [
        {
          "id": 46774,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></span></span></p>"
        },
        {
          "id": 46775,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin</span></span></span></span></p>"
        },
        {
          "id": 46776,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol </span></span></span></span></p>"
        },
        {
          "id": 46777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic drug that should be stopped immediately with a creatinine of 5.6mg/dl? (AIIMS NOV 2018)</span></span></span></span></p>",
      "unique_key": "Q7531235",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365481,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Metformin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin, a commonly prescribed medication for type 2 diabetes, primarily works by reducing hepatic glucose production. It is contraindicated in patients with significant renal impairment due to the risk of lactic acidosis, a potentially life-threatening condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is to be stopped if creatinine level &gt;1.5mg/dl in men and &gt;1.4mg/dl in women</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MOA of metformin- reduces hepatic glucose production.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adverse effects - nausea, diarrhea, lactic acidosis, vit b12 deficiency</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraindications:&nbsp; serum creatinine 1.5 (in males)/ 1.4(females)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GFR&lt;30ml/min, Unstable CHF, Hepatic failure, Acidosis, Hospitalized patients who cannot take anything orally</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Linagliptin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a DPP-4 inhibitor, which does not require adjustment for kidney disease and is not directly harmful in renal failure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metoprolol:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A beta-blocker used for cardiovascular conditions including hypertension; not directly affected by renal function in terms of drug safety, though dosing may need adjustment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Insulin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Often required in higher doses or with careful monitoring in renal impairment due to decreased insulin clearance, but not contraindicated.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin should be discontinued in patients with a creatinine level above 1.5 mg/dL for men and 1.4 mg/dL for women, or a GFR below 30 mL/min to avoid the risk of lactic acidosis, especially in the context of significant renal impairment.</span></span></span></span></p>",
      "correct_choice_id": 46774,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24767,
      "choices": [
        {
          "id": 99029,
          "text": "<p><span style=\"font-size:11.0pt;\">Torsade’s de pointes</span></p>"
        },
        {
          "id": 99030,
          "text": "<p><span style=\"font-size:11.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 99031,
          "text": "<p><span style=\"font-size:11.0pt;\">Atrial flutter</span></p>"
        },
        {
          "id": 99032,
          "text": "<p><span style=\"font-size:11.0pt;\">Monomorphic ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the given ECG? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-133825.png\" alt=\"\" width=\"300\" height=\"227\"></span></p>",
      "unique_key": "Q4433131",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365486,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Torsade’s de pointes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsade’s de pointes is characterized by a polymorphic ventricular tachycardia with varying QRS complex amplitudes and a twisting around the baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ventricular fibrillation:</strong> Characterized by a chaotic and irregular waveform without identifiable QRS complexes.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Atrial flutter</strong>: Shows a sawtooth pattern of atrial activity.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Monomorphic ventricular tachycardia:</strong> Shows uniform QRS complexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsade’s de pointes are a type of polymorphic ventricular tachycardia with a characteristic twisting pattern.</span></p>",
      "correct_choice_id": 99029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66054,
      "choices": [
        {
          "id": 263365,
          "text": "<p><span style=\"font-size:12.0pt;\">Tracheostomy</span></p>"
        },
        {
          "id": 263366,
          "text": "<p><span style=\"font-size:12.0pt;\">Orotracheal intubation</span></p>"
        },
        {
          "id": 263367,
          "text": "<p><span style=\"font-size:12.0pt;\">Nasotracheal intubation</span></p>"
        },
        {
          "id": 263368,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxygen therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old male presents with cervical spine injury and respiratory distress following a road traffic accident. There is no obvious facial trauma. What is the most appropriate initial airway management? [Twisted PYQ]</span></p>",
      "unique_key": "Q5298353",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Orotracheal intubation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cervical spine injury without facial trauma, rapid sequence orotracheal intubation with manual in-line stabilization is the preferred initial airway management. This approach secures the airway while minimizing cervical spine movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tracheostomy</strong>: Too invasive as first-line management when other airways are accessible</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nasotracheal intubation</strong>: Contraindicated in suspected base of skull fractures and requires head manipulation</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oxygen therapy</strong>: Insufficient for definitive airway protection in trauma</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To understand that orotracheal intubation with cervical spine precautions is the first-line airway management in trauma without facial injuries, while tracheostomy is reserved for cases where other methods are contraindicated or impossible.</span></p>",
      "correct_choice_id": 263366,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55352,
      "choices": [
        {
          "id": 220869,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ezetimibe</span></span></p>"
        },
        {
          "id": 220870,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Niacin</span></span></p>"
        },
        {
          "id": 220871,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gemfibrozil</span></span></p>"
        },
        {
          "id": 220872,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cholestyramine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 54-year-old man with dyslipidemia has persistently elevated triglyceride levels (600 mg/dL) despite treatment with rosuvastatin. What will be the next step?<strong> </strong>(FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q4938289",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365483,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Gemfibrozil</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In cases where a patient has dyslipidemia with persistently elevated triglyceride levels, particularly above 500 mg/dL, there is a significant risk of developing pancreatitis. The primary goal in such situations is to lower the triglyceride levels to mitigate this risk. Fibrates, such as gemfibrozil or fenofibrate, are the treatment of choice for reducing triglyceride levels effectively. They act by decreasing the hepatic secretion of very-low-density lipoprotein (VLDL) and increasing the clearance of triglycerides from the blood.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Ezetimibe:</strong> Ezetimibe is used to reduce low-density lipoprotein (LDL) cholesterol levels. It works by inhibiting the absorption of cholesterol in the small intestine. While it is effective for lowering LDL, it is not the first-line treatment for elevated triglycerides.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Niacin:</strong> Niacin, or vitamin B3, was previously used to lower both LDL and triglyceride levels. However, it is no longer commonly used in practice due to its side effects and lack of significant additional benefit over other treatments.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Cholestyramine:</strong> Cholestyramine is a bile acid sequestrant that is primarily used to lower LDL cholesterol. It is not particularly effective in reducing triglyceride levels and can cause gastrointestinal side effects, making it a less favorable option for this condition.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">For patients with triglyceride levels above 500 mg/dL, fibrates such as gemfibrozil are the preferred treatment to reduce the risk of pancreatitis.</span></span></p>",
      "correct_choice_id": 220871,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}